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Ultraviolet radiation (UVR) can profoundly affect human skin as it functionally 
naked unlike other furred animals. UV-irradiated skin exhibits several unique
features, including sunburn and tanning responses at the acute level, an 
increased risk of developing skin cancer, immunosuppression and photoaging 
at the chronic level. Among these, tanning (melanogenesis), sunburn and 
wrinkles are being actively investigated in the clinical and cosmetic fields.
The first chapter discusses the molecular mechanism of anti-melanogenic 
effects of 4-n-butylresorcinol investigated. 4-n-butylresorcinol is a competitive 
inhibitor of tyrosinase and has been used as an anti-melanogenic agent.
However, its anti-melanogenic mechanism(s) in cell is not fully understood. In 
this study, it was discovered that 4-n-butylresorcinol regulates tyrosinase 
protein level, but not its mRNA level, through promotion of the proteolytic 
degradation of tyrosinase. Moreover, 4-n-butylresorcinol-mediated activation 
of p38 MAPK was observed, which promotes ubiquitination of tyrosinase. 
Treating B16F10 cells with E64 or proteasome inhibitors restores 4-n-
butylresorcinol-mediated decrease of tyrosinase. These findings will assist with
the development new, effective and safe agents for the treatment of 
hyperpigmentation disorders.
The second and third chapters discuss the role of transglutaminase 2 (TG2) 
in UV-irradiated epidermal and dermal tissues investigated. TG2 catalyzes the 
posttranslational modification of substrate proteins, including crosslinking, 
polyamination and deamidation. While epidermal keratinocytes and dermal 
fibroblasts have been known to express TG2, there still is lack of knowledge 
regarding this enzyme’s role in regulation of skin homeostasis.
Chapter 2 discusses the role of TG2 in UV-induced acute skin inflammation 
was investigated through the use of human and mouse keratinocytes as well as 
TG2-deficient mice. TG2-deficient mice exhibited reduced UV-induced skin 
inflammatory phenotypes, including decreased erythema, edema, dilation of 
blood vessels, immune cell infiltration and expression of inflammatory 
cytokines. Using HaCaT cells and primary mouse keratinocytes, it was
observed that TG2 is activated following UV irradiation without increase of its 
protein level and that UV-induced phospholipase C activation followed by ER 
calcium release was a prerequisite for TG2 activation. Moreover, activated TG2 
enhanced transcriptional activity of NF- which leads expression of 




not only indicate that TG2 serve as a critical mediator of cytokine expression 
in the UV-induced inflammatory response of keratinocytes, but also suggest 
that TG2 inhibition might be a useful target for the prevention of sunburn.
Chapter 3 discusses the role of fibroblasts TG2 in UV-exposed fibroblasts
investigated by using primary human and mouse dermal fibroblasts and ex vivo
mouse skin culture model. In this study, it was revealed that human matrix 
metalloproteinase (MMP) -1 and -3, and mouse MMP-13 expressions are 
regulated by UV-induced activation of TG2 as well as its protein level. It was 
also found that TG2 regulates MMP gene transcription through NF-	
than AP-1 pathway. This study provides a new insight that TG2 can be a new 
therapeutic target for the treatment for UV-induced skin disorders like 
photoaging.
In summary, all of above studies have focused on elucidating molecular 
mechanisms of responses in UV-irradiated skin cells, including melanocytes, 
keratinocytes and fibroblasts, and suggest new molecular mechanisms that can 
be considered in treating of UV-induced skin damages.
Keywords: 4-n-butylresorcinol, melanogenesis, tyrosinase, transglutaminase 2, 
inflammatory cytokines, matrix metalloproteinase 1, NF- 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General Introduction
Human skin is a stratified tissue which consists of four layers; the stratum 
corneum, the viable epidermis, the dermis and the hypodermis. Furthermore, 
skin is a heterogeneous organ since it contains four types of independent mini-
organs, such as nails, pilosebaceous follicles and hair, eccrine sweat glands and 
apocrine sweat glands. Skin performs various functions such as self-
maintenance, self-repair, protection against physical/chemical/biological 
insults, sensory function, regulating body temperature, ossification, immune 
function and even socio-psychological functions (1). Furthermore, recent 
evidence indicates that this organ is hardwired into the body’s key neuro-
immuno-endocrine axis (2, 3).
Unlike non-human primates, most of the surface of human body is naked 
except for the scalp, armpit and groin. Human lineages lost their hair throughout 
the evolutionary history and instead acquired efficient thermoregulation 
systems through the use of eccrine sweat glands (4). This advanced cooling 
system led to increased human activities during hot daytime. However, loss of 
body hair brought not only considerable advantages, but also a notable 
disadvantage, namely, the protective function of hair.
Among many insults that could have been protected by hair, human skin can 
be tremendously affected by ultraviolet radiation (UVR) which is subdivided 
into three classes, according to wavelength; UVA (400 ~ 320 nm) constitutes 
90 ~ 95% of total UVR which can reach onto the ground; UVB (320 ~ 290 nm) 
occupies the remaining 5 ~ 10% which varies, depending on the seasons, 
latitude and time; UVC (290 ~ 100 nm) possesses the most intensive energy,
but its effects on human skin is negligible since the radiation with this 
wavelength is mostly absorbed by the ozone layer. In other words, UVA and 
UVB are the wavelength classes of UVR that can affect the homeostasis of 
human skin. 
Human skin responds in various ways upon exposure to UVR. As a short-
term response, UV-exposed skin shows an acute inflammatory response that is 
caused by the increased production of inflammatory cytokines (5), and tanning 
response to protect against further UVR penetration into the skin by
synthesizing melanin, a natural sunscreen (6). When skin is exposed to UVR 
over a long period of time, the chances of the development of skin cancer and 
wrinkle formations are increased by accumulated UV-induced DNA damage 
and the degradation of skin extracellular matrix (ECM) proteins, respectively 
(7). This study focused on elucidating the molecular mechanisms of 
responsiveness of skin cells consequence to UV irradiation.
The UV irradiation onto skin induces the tanning response attributed to 
melanogenesis, increased synthesis of the melanin pigment (6). Furthermore, 
repeated exposure to UVR contributes to the development of pigmentary 
disorders, such as melasma, ephelides and solar lentigines on sun-exposed 
lesions (8, 9). Since these pigmentary disorders are not favored in cosmetic and 
clinical perspectives, there are considerable interests in the development of 
anti-melanogenic agents. Chapter 1 discusses the mechanisms of anti-
melanogenic effect of 4-n-butylresorcinol. 4-n-butylresorcinol is a derivative 
of resorcinol, which is commercially used in the cosmetic industry for 
whitening application. However, the only known mechanism of this agent is as 
an inhibitor of tyrosinase and tyrosinase-related protein-1 (TYRP-1) (10). In 
this study, cellular tyrosinase protein levels in B16F10 melanoma cells were 
observed to have decreased following 4-n-butylresorcinol treatment. This 
phenomenon was associated with the accelerated proteolytic degradation of 
tyrosinase. This result is expected to suggest a new mechanism of 4-n-
butylresorcinol and to contribute to the development of more effective 
derivatives of 4-n-butylresorcinol which can be used to treat hyperpigmentary 
disorders.
Another important feature of UV-exposed skin is sunburn which is caused 
by UV-damaged epidermal keratinocytes (5). Chapter 2 discusses the role of 
transglutaminase 2 (TG2) investigated in UVB-induced acute skin 
inflammation using human keratinocytes and TG2-deficient mice. Although 
keratinocytes express TG2, its roles in maintaining keratinocytes homeostasis
are poorly understood. In this study, it was discovered that UV-irradiated 
keratinocytes induce the activation of TG2. Additionally, it was concluded that
the PLC-IP3-IP3R axis plays a central role in activating TG2. The enzymatic 
activation of TG2 further promoted activation of NF-
	-known 
master transcription factor for inflammatory cytokine genes. This ultimately 
leads to skin inflammation by inducing immune cell infiltration, erythema, 
edema and dilation of blood vessels in the UV-exposed lesions. This study 
suggests that the regulation of TG2 activity following UV irradiation may serve 
as a new therapeutic target for treating UV-induced acute skin inflammation.
UV irradiation on the dermal skin causes remodeling of dermal ECM,
leading to skin aging. One of the prominent features of chronically UV-
damaged skin is the formation of deep and coarse wrinkles which are distinct 
from the fine wrinkles present in chronologically aged skin. One of the causes 
of skin wrinkles is alterations in skin ECM structure (7). A set of proteins 
construct a dynamic structure of the ECM- fibrous proteins (collagens and 
elastin fibers), glycoproteins (fibronectins and laminins) and proteoglycans (7).
Collagen constitutes major families of ECM proteins, thereby playing a pivotal 
role in wrinkle formation. Homeostasis of collagen is maintained by synthetic 
and degradative pathways which can be disturbed by intrinsic and extrinsic 
factors. MMP family proteins have a critical role in the degradative pathway of 
ECM proteins such as collagen and elastin (2). MMPs are zinc-dependent 
endopeptidases which are subdivided into several groups including collagenase, 
gelatinase, stromelysin and matrilysin, according to their substrates specificity 
(11). It is MMP-1 that plays a significant role in initiating the wrinkle formation 
of human skin as it is capable of degrading intact fibrillar collagen (12). Chapter 
3 introduces the role of TG2 in regulating the expression of MMPs in dermal 
fibroblasts. The role of TG2 in regulating the expression of human MMP-1 and 
-3, and mouse MMP-13 was investigated in this study. Similar to chapter 2, 
UVB irradiation induces the activation of fibroblast TG2, followed by NF-
activation that further facilitates MMP-1 expression at transcriptional level. 
This indicates that regulation of TG2 activity in dermal fibroblasts may be a 
new strategy for the alleviation of UV-mediated wrinkle formation at the 
chronic level by preventing the degradation of dermal collagen.
The responses of UVR stimulated skin cells, such as melanocytes, 
keratinocytes and fibroblasts, were investigated by performing the studies 
described above. Since UVR is one of the most prominent exogenous stresses 
for skin, understanding the biochemical influences of the UV on human is 
critical in proceeding toward the prevention of UV-induced skin damage 
clinically and cosmetically. These studies will provide new insights in the 
development of strategies for anti-aging agents based on molecular 
mechanisms, which will be distinct from conventional treatment. 
CHAPTER 1
4-n-butylresorcinol enhances proteolytic 
degradation of tyrosinase in B16F10 
melanoma cells
1.1 INTRODUCTION
Melanins are brown or black pigments in the skin that are synthesized in 
melanosomes, transferred to keratinocytes, and distributed around cell nuclei 
(13). These processes of pigmentation are influenced by UV irradiation, 
inflammatory cytokines secreted from keratinocytes and fibroblasts, and 
hormonal status (6, 14-17). Of these, UV irradiation is the most critical factor 
to increase pigmentation by stimulating melanin synthesis, proliferation of 
melanocytes and transfer of melanosomes, known as tanning response (6).
Melanin pigments absorb and scatter UV irradiation, thereby protecting 
epidermal keratinocytes from UV-induced DNA damage. On the other hand, 
aberrantly stimulated melanin production by UV irradiation is thought to cause 
common hypermelanotic skin disorders on sun-exposed areas in the face, such 
as melasma, ephelides and solar lentigines (8, 9).
In melanosomes, eumelanin, and pheomelanin are synthesized from tyrosine 
through a series of oxidative reaction, including the conversion of -tyrosine to 
3,4-dihydroxyphenylalanine catalyzed by tyrosinase, a rate-limiting step of 
melanin biosynthesis (Fig. 1-1) (6, 18). Thus the expression level of tyrosinase 
is a critical determinant for melanin production. At the transcriptional level, 
tyrosinase mRNA is upregulated by microphthalmia-associated transcriptional 
factor (MITF), a master regulator of genes involved in t he  proliferation, 
differentiation and melanogenesis of melanocytes (19, 20), w h i l e MITF 
expression is increased by -melanocyte stimulating hormone MSH)-
mediated, cAMP-dependent CREB phosphorylation (21). Because UV 
irradiation increases MSH secretion from keratinocytes through the p53-
dependent signaling pathway (14), tyrosinase levels depend on the activities of 
p53 and cAMP signals in keratinocyte and melanocyte, respectively (Fig. 1-2). 
At the post-translational level, tyrosinase is glycosylated in the endoplasmic 
reticulum (ER), and further matured in the Golgi (22-24). The protein level of 
tyrosinase is also regulated by two degradation systems, the proteasomal and 
endosomal/lysosomal systems for proteolysis of misfolded of unfolded proteins 
during maturation processing (25-27).
Regulation of tyrosinase activity and protein level is a target for treating 
hyperpigmentation disorders and for whitening skin after sunburn. A number of 
compounds, including kojic acid, arbutin, hydroquinone, and akylresorcinols, 
namely 4-n-butylresorcinol, 4-n-hexylresorcinol and 4-(1-phenylethyl)-
resorcinol, are known to inhibit tyrosinase activity and are currently utilized for 
cosmetic purpose (28-33). On the other hand, several agents, such as linoleic 
acid, 25-hydroxycholesterol, phynylthiourea, and 1-phenyl-3-(2-thiazolyl)-2-
thiourea, inhibit tyrosinase by decreasing its protein level through accelerating
the degradation system (22, 23, 34, 35)
On these, 4-n-butylresorcinol is a derivative of resorcinol and inhibits 
tyrosinase and tyrosinase-related protein-1 (TRP-1) in vitro as well as in B16 
cell line (10). In clinical studies, topical application of 4-n-butylresorcinol 
showed a significant decrease of the melanin index in patients with melasma 
(36-38). In this study, we found that 4-n-butylresorcinol reduces the protein 
level of tyrosinase with no change in its mRNA level. Analyses with 
glycosidase digestion and protease inhibitors showed that 4-n-butylresorcinol 
enhances tyrosinase degradation not by interfering with its maturation 
processing, but by increasing the activities of the proteasomal and 
eondosomal/lysosomal degradation systems. Our results indicate that 
enhancement of proteolytic degradation is a new mechanism by which 4-n-
butylresorcinol inhibits tyrosinase in melanocytes. It would be interesting to 
know if this mechanism is also applicable to other two commercially available 
akylresorcinols – hexylresorcinol and phenylethylresorcinol.
Figure 1-1. The mammalian eumelanogenic pathway. Tyrosinase is a rate-
limiting enzyme of melanogenesis. TRP1 and TRP2 determine the type and 
amount of eumelanins. DIH: 5,6-dihydroxyindole; IQ: 5,6-indolequinone; 
DIHCA: DHI-2-carboxylic acid; IQCA: indole-2-carboxylic acid-5,6-quinone. 
Modified image from reference (39).
Figure 1-2. Signaling pathway of UV-induced melanogenesis. UV-exposed 
keratinocytes secret MSH through the p53 dependent pathway. Secreted 
MSH binds with MC1R which is expressed on melanocyte plasma memebrane. 
This receptor-ligand binding increases cytosolic cAMP level and followed by 
PKA-dependent phosphorylation of CREB. Phosphorylated CREB translocates 
to the nucleus and initiates MITF transcription, a master transcription factor of 
melanogenesis. N: nucleus; C: cytosol, P: phosphorylation.
1.2 MATERIALS AND METHODS
1.2.1 Cell culture
B16F10 cells were cultured in Dulbecco’s modified Eagles’s medium (DMEM, 
Welgene, Gyeongsan, South Korea) containing 10% heat-inactivated fetal 
bovine serum (Hyclone), 100 U/ml of penicillin and 100 g/ml of streptomycin 
sulfate (GIBCO) under 5% CO2 atmosphere at 37°C. To examine the effect of 
4-n-butylresorcinol on melanin synthesis, cells were treated with 4-n-
butylresorcinol (Enprani, Incheon, South Korea), MSH (Sigma-Aldrich Co., 
St Louis, MO, USA), E64 (Sigma-Aldrich Co., St Louis, MO, USA), and/or 
proteasome inhibitor cocktail (Enzo Life Sciences, San Diego, CA, USA) for t
he indicated period. 
1.2.2 Tyrosinase activity assay
Mushroom tyrosinase (10 U, Sigma-Aldrich Co., St Louis, MO, USA) was 
incubated with various concentrations of 4-n-butylresorcinol in a  reaction 
buffer (80 mM potassium phosphate, pH 6.8 and 200 M L-tyrosine) at 37°C
for 30 min. Tyrosinase activity was estimated by measuring the absorbance at 
475 nm.
To assess the effect of 4-n-butylresorcinol on tyrosinase activity in live cells, 
B16F10 cells (1.5 x 105/well) were cultured in 6-well plate for 18 h, and then 
treated with 5 nM MSH and/or 10 M 4-n-butylresorcinol for 2 days. Cells 
were washed twice with phosphate buffered saline (PBS) and lysed in 0.1 M
potassium phosphate buffer, pH 6.8 with 1% Triton X-100, followed by 
centrifugation for 10 min (10,000 ×g) at 4°C. After quantification of protein 
concentrations with the BCA method, L-DOPA (0.5 mM, Sigma-Aldrich Co., 
St Louis, MO, USA) was added to the supernatant, and the mixture was 
incubated at 37°C. Tyrosinase activity was estimated by measuring the 
absorbance at 475 nm. For comparison, tyrosinase activity in the cell lysates 
prepared from untreated B16F10 cells was determined in the presence of 5 nM 
MSH and/or 10 M 4-n-butylresorcinol.
1.2.3 Measurement of melanin content
B16F10 cells (1.5 x 105) were cultured in 6 well plate for 18 h. Cells were 
washed twice with PBS and treated with MSH and 4-n-butylresorcinol diluted 
in phenol red-free culture media for 2 days. Media was collected from each well 
and centrifuged for 5 min (1,500 x g) at 4°C to remove cellular debris. Melanin 
content in the medium was determined by measuring the absorbance at 405 nm. 
To quantify cellular melanin content, the cells were washed twice with PBS, 
detached by treatment with trypsin, and centrifuged for 5 min (1,500 x g) at 
4°C. Cell pellets were lysed in the dissolving buffer (1 N NaOH and 10% 
dimethyl sulfoxide) by boiling for 1 h. Melanin content in each sample was 
determined by measuring the absorbance at 470 nm. The melanin standard 
curve was prepared with synthetic melanin (Sigma-Aldrich Co., St Louis, MO, 
USA) in the range of 1-40 g/ml. Melanin content was normalized using cell 
numbers.
1.2.4 Melanosome isolation
Melanosomes were isolated as described previously (27) with slight 
modifications. Cells (1 x 107) were washed twice with PBS and exposed to 
repeated freeze-thaw in a buffer containing 250 mM sucrose, 20 mM Tris-HCl, 
pH 7.2, 150 mM NaCl, and 1 mM EDTA, followed by centrifugation for 5 min 
(1000 × g) at 4°C. The supernatant was carefully separated and layered over an 
equal volume of 1.5 M sucrose in 20 mM Tris-HCl, pH 7.2, 150 mM NaCl and 
1 mM EDTA, followed by centrifugation for 30 min (50,000 x g) at 4°C. The 
supernatant and pellet were collected for the cytoplasmic and melanosome 
fraction, respectively. The pellet was resuspended in 60 mM Tris-HCl, pH 6.8, 
100 mM dithiothreitol, and 2% sodium dodecyl sulfate (SDS). To check the 
purity of each fraction, immunoblotting analysis was performed using anti-
PMEL17 and anti-calregulin antibodies for the melanosome and cytoplasm, 
respectively.
1.2.5 Western blot analysis
Cells were lysed in buffer (10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 150 mM 
NaCl, 1% Triton X-100, protease inhibitor cocktail (Roche, Indianapolis, IN, 
USA)) and centrifuged at 12,000 x g for 10 min at 4°C. After quantitating the 
protein concentration of each cell extract using the BCA method, samples were 
boiled in a loading buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 0.14 M 2-
mercaptoehthanol, 10% glycerol, and 0.2% bromophenol blue) for 5 min, 
separated on SDS-PAGE, and transferred onto nitrocellulose membranes. The 
membranes were washed with Tris-buffered saline containing 0.1% Tween-20
(TBS-T), blocked with 5% skim milk in TBS-T, and probed with monoclonal 
antibodies specific for tyrosinase, TRP-1, TRP-2, PMEL17, MART-1, 
calregulin, ubiquitin (Santa Cruz Biotechnologies, Santa Cruz, CA, USA), p38, 
p-p38 (Cell Signaling Technology, Beverly, MA, USA), and beta-actin (Sigma, 
St. Louis, MO, USA). After washing three times with TBS-T, the membranes 
were incubated with a 1:2000 diluted secondary antibody coupled to 
horseradish peroxidase (Thermo Scientific Pierce, Rockford, IL, USA) for 1 h, 
and washed five times with TBS-T. The immunoreactive proteins were 
visualized with enhanced chemiluminescence detection (ECL, Thermo 
Scientific Pierce). For immunoprecipitation, cells were lysed in RIPA buffer 
with proteasome inhibitor cocktails. Extracted proteins (0.5 mg) were used in 
each immunoprecipitation with an anti-ubiquitin antibody. Prepared samples 
were subjected to western blot analysis using an anti-tyrosinase antibody.
1.2.6 QRT-PCR
RNA of B16F10 cells was purified with Total RNA Kit I (OMEGA Bio-Tek, 
Norcross, GA, USA). One g of purified RNA was reverse transcribed using 
SuperScript II Reverse Transcriptase (Invitrogen, NY, USA). QRT- PCR was 
performed with EvaGreen qPCR Mastermix (abm, Richmond, CA, USA) using 
an iCycler RT-PCR instrument (Bio-Rad, Hercules, CA, USA). The following 
specific primers were used.
Levels of tyrosinase mRNA were estimated by the 2- method (40) and 
normalized to GAPDH levels.
1.2.7 Glycosylation assay
B16F10 cells were lysed by sonication in PBS containing protease inhibitor 
cocktail (Roche, Indianapolis, IN, USA) and centrifuged at 12,000 x g for 5 min 
at 4°C. After quantitating the protein concentration of the supernatants by BCA 
assay, a glycosylation assay was performed with 10 g of proteins per sample 
using Endo H and PNGase F (New England BioLabs, Ipswich, MA, USA), in 
accordance with the manufacturer’s procedure.
1.2.8 Confocal microscopy
B16F10 cells were cultured on microscope cover glasses. Cells were fixed with 
4% formaldehyde for 20 min at room temperature, washed twice with PBS, and 
permeabilized with 0.1% Triton X-100 in PBS (PBST) for 5 min. Cover glasses 
were blocked with 1% bovine serum albumin in PBST for 30 min, probed with 
mouse anti-MART1 or rabbit anti-tyrosinase antibody (Santa Cruz 
Biotechnologies, Santa Cruz, CA, USA), followed by Alexa Fluor 488-
conjugated goat anti-rabbit IgG (H+L) antibody (Molecular Probes, Inc., 
Eugene, OR, USA) or Alexa Fluor 488 donkey anti-rabbit antibody (Invitrogen). 




Cells were mounted with GEL/MOUNTTM (Biomeda corp.) and observed 
with a FluoView 1000 confocal microscope (Olympus, Tokyo, Japan). The 
nucleus was detected using 4,6-diamidino-2-phenylindole (DAPI, Roche, Palo 
Alto, CA, USA). 
1.2.9 UVB induced hyperpigmentation and 
immunohistochemical analysis
Five weeks old female brown guinea pigs were purchased from Oriental Yeast 
Co., LTD (Tokyo, Japan). These animals were housed under standard 
experimental conditions (22±1 , 55±5% humidity, 12-hour light and 12-hour 
dark cycle) and were fed on a standard diet (Guinea pig Diet, Cargill Agri 
Purina Inc, Seongnam, Korea) with freely available water. Animal experiments 
were conducted in accordance with the Guide for the Care and Use of 
Laboratory Animals (NIH Publication No. 85-23, 1996) and approved by the 
Korea Conformity Laboratories Institutional Animal Care and Use Committee 
(Approval No.: IA12-00036). The dorsal skin was shaved with an electric 
shaver and was subsequently exposed to 500mJ/cm2 of UVB (per exposure) 
(Sankyo Denki, Tokyo, Japan) following on a week of adaptation. The UVB 
irradiation was repeated over three successive days. Subsequent to UVB 
irradiation vehicle, 2% arbutin or 0.3% 4-n-butylresorcinol cream, were 
topically applied to the UVB irradiated skin (1.5 cm x 1.5 cm) every two days 
for four weeks, respectively. The creams were kindly provided by Enprani 
(Incheon, Korea). A Mexameter (Courage and Khazaka, Cologne, Germany)
was employed to determine the delta L values. 
For immunohistochemical analysis, the guinea pigs were euthanized by CO2
asphyxiation, after which the skin was harvested and fixed in 4% 
paraformaldehyde. The skin samples were sent for hematoxylin & eosin 
staining or Masson-Fontana staining, to the Korea Conformity Laboratories 
(Incheon, Korea)
1.2.10 Statistical analysis
Statistical evaluations were conducted with Prism 5 software (GraphPad, San 
Diego, CA) using one-way or two-way ANOVA. P < 0.05 was considered 
significant.
1.3 RESULTS
1.3.1 Intact cell is required for 4-n-butylresorcinol to 
effectively inhibit B16F10 cell tyrosinase
4-n-butylresorcinol is a well-known tyrosinase inhibitor (10). We first 
determined the effective dose of 4-n-butylresorcinol for inhibiting purified 
mushroom tyrosinase. 4-n-butylresorcinol reduced tyrosinase activity in a 
concentration dependent manner, and 10 M 4-n-butylresorcinol was found t
o completely inhibit mushroom tyrosinase (Fig. 1-3A). To evaluate t h e 
inhibitory capacity of 4-n-butylresorcinol in MSH-stimulated melanogenesis, 
we compared this effective dose with that for tyrosinase in B16F10 melanoma 
cells. Addition of 10 and 50 M 4-n-butylresorcinol to the lysate of MSH-
treated B16F10 cells reduced tyrosinase activity to 60% and 20% of the control 
level, respectively, and 100 M of 4-n-butylresorcinol completely inhibited 
B16F10 cell tyrosinase (Fig. 1-3B), indicating that B16F10 cell tyrosinase is 
more resistant than mushroom tyrosinase to 4-n-butylresorcinol. By contrast, 
when B16F10 cells were cultured with MSH and 10 M 4-n-butylresorcinol
for 2 days, tyrosinase activity was reduced to 35% of MSH-induced activity 
(Fig. 1-3C), suggesting that an intact cell is required for 4-n-butylresorcinol to 
inhibit B16F10 cell tyrosinase. To confirm these results, we examined the effect 
of 4-n-butylresorcinol on MSH-stimulated melanin synthesis. Treatment with 
MSH caused a 40% increase in extracellular melanin secreted from B16F10 
cells (Fig. 1-3D), and an approximately three-fold increase in melanin content 
per cell (Fig. 1-3E). Under the same experimental conditions, 10 M 4-n-
butylresorcinol reduced the amount of melanin to the control levels (Fig. 1-3D–
F). These results suggest that 4-n-butylresorcinol may suppress intracellular 
tyrosinase through unidentified mechanism(s) in addition to direct inhibition of 
tyrosinase activity.
Figure 1-3. 4-n-butylresorcinol inhibits MSH-induced tyrosinase activity 
and melanin synthesis to the level of MSH-untreated cells. (A) Mushroom 
tyrosinase was incubated with various concentrations of 4-n-butylresorcinol at 
37°C for 30 min and then tyrosinase activity was measured. (B) B16F10 cell 
lysates were incubated with 5 nM MSH and various concentrations of 4-n-
butylresorcinol at 37°C for 30 min and then tyrosinase activity was measured. 
(C–E) B16F10 cells were cultured with 5 nM MSH in the presence or absence 
of 10 M 4-n-butylresrocinol for 48 h. After cell lysis, tyrosinase activity was 
measured (C), concentration of secreted melanin was determined in cultured 
media (D) and concentration of intracellular melanin was measured in the cell 
lysates (E). Results are presented as the mean ± s.e.m. Data are representative 
of at least three experiments. (F) Microscopy images showed melanin 
deposition in 4-n-butyl-resorcinol-treated B16F10 cells. Magnification x100, 
*** P< 0.001 compared with control.
1.3.2 4-n-butylresorcinol reduces protein levels of 
tyrosinase in B16F10 cells
To explore the inhibitory mechanism of 4-n-butylresorcinol for intracellular 
tyrosinase, we tested whether 4-n-butylresorcinol could affect the tyrosinase 
expression in B16F10 cells. In control and MSH-treated cells, 4-n-
butylresorcinol had no effect on the levels of MITF mRNA and protein (data 
not shown). Consistent with these results, the mRNA levels of tyrosinase were 
not changed by treatment with 4-n-butylresorcinol (Fig. 1-4A). By contrast, 
western blot analysis revealed that t h e  protein level of tyrosinase was 
decreased by treatment with 4-n-butylresorcinol in both control and MSH-
treated B16F10 cells, whereas the protein levels of TRP-1, TRP-2 and Pmel17, 
which are known to be MITF-dependent, were not significantly changed by 4-
n-butylresorcinol treatment (Fig. 1-4B). These results suggest that 4-n-
butylresorcinol negatively regulates t h e  protein level of tyrosinase in a 
tyrosinase-specific manner
Figure 1-4. 4-n-butylresorcinol reduces level of tyrosinase protein but not 
mRNA. (A) B16F10 cells were cultured in media containing 5 nM MSH and 
10 M 4-n-butylresrocinol for 6 h. Cell lysate was prepared and mRNA level 
of tyrosinase was estimated by QRT-PCR. (B) B16F10 cell lysate was 
subjected to western blot analyses using antibodies specific for tyrosinase, 
TRP-1, TRP-2, and PMEL17. Right panel shows protein level of tyrosinase 
estimated by densitometric analysis. Results are presented as the mean ± s.e.m. 
Data are representative of at least three experiments. **P<0.01, ***P < 0.001 
compared with control.
1.3.3 4-n-butylresorcinol has no effect on glycosylation and 
maturation of tyrosinase 
A newly synthesized tyrosinase is glycosylated and further maturated in the 
endoplasmic reticulum (ER) and Golgi, and then transported to melanosome
(41). Tyrosinase glycosylation helps to facilitate correct folding and trafficking 
to melanosome; thus aberration of glycosylation causes the retention of 
tyrosinase in the ER that leads to degradation (42). To determine whether 4-n-
butylresorcinol could inhibit these processing, we examined the tyrosinase 
levels in the melanosome. In control and MSH-treated B16F10 cells, 4-n-
butylresorcinol treatment caused a decrease in tyrosinase co-localization with 
MART-1, a melanosomal marker protein (Fig. 1-5A). Moreover, western 
blotting analysis also showed a decrease of melanosomal tyrosinase in 4-n-
butylresocinol treated cells (Fig. 1-5B), indicating an involvement of 4-n-
butylresocinol in the post-translational processing of tyrosinase. 
We then investigated the location where glycosylation processing is 
hampered. To this end, cell lysates obtained after 4-n-butylresorcinol treatment 
were digested with Endo H and PNGase F glycosidase. Endo H cleaves sugar 
chains of tyrosinase processed in the ER but not in the Golgi, whereas PNGase 
F cleaves sugar chains processed both in the ER and in the Golgi, producing 
deglycosylated tyrosinase. Western blotting analysis revealed that most of 
tyrosinase was not digested by Endo H, indicating that tyrosinase in the 4-n-
butylresorcinol treated cells is fully matured and not retained in the ER (Fig. 1-
5C, left). In addition, the protein level of PNGase F-digested tyrosinase was 
reduced by 4-n-butylresorcinol to a similar extent with the control cell lysates 
(Fig. 1-5C, right). These results indicate that glycosylation processing of 
tyrosinase, which occurred in the ER, is not affected by 4-n-butylresorcinol.
Figure 1-5. 4-n-butylresorcinol does not inhibit glycosylation processing of 
tyrosinase. (A) Confocal microscopy images show B16F10 cells 
immunostained with anti-tyrosinase or anti-MART-1 antibody. Cells were 
cultured in media containing 5nM MSH and 10 M 4-n-butylresrocinol for 6 
h. MART-1 was used as a marker for melanosomes. DAPI staining showed 
nuclei. Scale bar, 20 m. (B) Melanosomal and cytoplasmic fractions were 
isoloated from B16F10 cells. The level of tyrosinase in each fraction was 
assessed by western blot analysis with anti-tyrosinase antibody. Pmel17 and
calregulin were used as a marker for melanosome and cytosol, respectively. (C) 
Lysates from B16F10 cells treated with Endo H (left panel) or PNGase F (right 
panel) were immunoblotted with the anti-tyrosinase antibody. Upper and lower 
bands indicate matured (glycosylated) and nascent (unglycosylated) forms of 
tyrosinase, respectively.
1.3.4 4-n-butylresorcinol enhances the degradation of 
tyrosinase 
The protein level of tyrosinase is regulated by a balance between production 
and degradation. Misfolded or unassembled tyrosinase is ubiquitinated and 
subsequently proteolyzed by proteasomes (34, 43-45). Moreover, tyrosinase is 
also degraded by lysosomal enzymes after Golgi maturation (22). Therefore, 
we tested if 4-n-butylresorcinol was involved in the proteolytic process of 
tyrosinase by using E64, a lysosomal protease inhibitor, and proteasome 
inhibitor cocktail (PIC). Western blot analysis showed that treatment of B16F10 
cells with E64 or PIC restored the protein levels of tyrosinase decreased by 4-
n-butylresorcinol (Fig. 1-4A). In accordance with these results, E64 or PIC 
treatment increased the levels of secreted extracellular melanin (Fig. 1-6B) and 
melanin content per cell (Fig. 1-6C) in 4-n-butylresorcinol-treated B16F10 cell
s , showing that E64 and PIC abrogated the inhibitory effect of 4-n-
butylresorcinol on melanin synthesis. In addition, because activation of p38 
MAPK induced proteasomal degradation of tyrosinase (46), we examined the
phosphorylation levels of p38 MAPK in B16F10 cells. As shown in Fig. 1-6D, 
4-n-butylresorcinol increased whereas MSH decreased the phosphorylation of 
p38 MAPK. Moreover, when lysates were immunoprecipitated with an anti-
tyrosinase antibody, there was a significant increase in ubiquitinated tyrosinase 
in 4-n-butylresorcinol-treated cells (Fig. 1-6E). These results indicate that 4-n-
butylresorcinol inhibits tyrosinase via the acceleration of proteasomal, as well 
as lysosomal, degradation.
Figure 1-6. 4-n-butylresorcinol promotes lysosomal and proteasomal 
degradation of tyrosinase. (A) B16F10 cells were cultured for 48 h in media 
containing 5 nM MSH and 10 M 4-n-butylresrocinol in the presence of 50 
M E64 (left panel) or proteasome inhibitor cocktail (0.5 x PIC, right panel). 
Total cell extracts were immunoblotted with anti-tyrosinase antibody. (B and C) 
Concentration of melanin was determined in the media (B) and in the cell 
lysates (C). Results are presented as the mean ± s.e.m. Data are representative 
of at least three experiments. *P < 0.05, **P < 0.01, ***P < 0.001. (D) Lysates 
prepared from B16F10 cells cultured for 48 h in the presence of 5 nM MSH 
and 10 M 4-n-butylresrocinol were immunoblotted with anti-phospho p38 
antibody. Total p38 protein was used as a loading control. (E) Lysates prepared 
from B16F10 cells cultured for 24 h in the presence of 5 nM MSH, 10 M 4-
n-butylresrocinol and PIC were immunoprecipitated with anti-tyrosinase 
antibody, and immunoblotted with anti-ubiquitin antibody and anti-IgG 
antibody
1.3.5 4-n-butylresorcinol attenuates UVB-induced 
melanogenesis in Guinea pig skin
Lastly, we investigated the in vivo efficacy of 4-n-butylresorcinol in a model 
animal system. A brown guinea pig was selected as an animal model of 
pigmentation, since they express active melanocytes in the basal layer of the 
interfollicular epidermis, which is similar to human skin. Furthermore, this 
animal has the ability to tan in response to UV radiation. 
Following the induction of the tanning response, vehicle or 2% arbutin or 
0.3% 4-n-butylresorcinol creams were applied to the UVB-irradiated lesions. 
Arbutin, which is a commercially using agent for whitening purposes (47), was 
used to compare efficacy with 4-n-butylresorcinol. Following four weeks of 
applications, the skin lesions were analyzed via Masson-Fontana staining to 
visualize the melanin deposition. UVB irradiation induced the formation of 
melanin deposit on the basal epidermis of only the vehicle applied lesion (Fig. 
1-7A). However, this melanin deposition was inhibited in the 2% arbutin or 0.3% 
4-n-butylresolcinol applied lesions, without changes to the skin structures (Fig. 
1-7A). Additionally, we measured the L value to quantify the deposited 
melanin content in the skin. As shown in Fig. 1-7B, UVB irradiation induced 
the darkening of the skin at an approximately three-fold high rate than for the 
un-irradiated lesions. The 2% arbutin cream slightly decreased the melanin 
content, however it was not statistically significant. However, the application 
of 0.3% 4-n-butylresorcinol cream almost completely blocked melanin 
synthesis, which was comparative to un-irradiated skin lesions. Furthermore, 
the 0.3% 4-n-butylresorcinol cream showed more superior effects for whitening 
in comparison with the 2% arbutin cream. These results suggest that 4-n-
butylresorcinol is a more potent agent for in vivo whitening than arbutin.
Figure 1-7. in vivo Whitening effect of 0.3% 4-n-butylresorcinol cream. 
Following the induction of tanning response on Guinea pig skin, vehicle or 2% 
arbutin or 0.3% 4-n-butylresorcinol creams were applied on the irradiated 
lesions for 4 weeks. (A) Histology of guinea pig skin. Scale bar, 200 m. (B) 
Delta L value was determined by Mexameter (n=3). Arb, arbutin. n.s., not 
significant, *P < 0.05, **P < 0.01, ***P < 0.001.
1.4 DISCUSSION
4-n-butylresorcinol is a resorcinol derivative that is known to exhibit anti-
melanogenic activity via direct inhibition of tyrosinase, a rate-limiting enzyme 
in melanogenesis (10, 37, 48). Its efficacy and safety have been proven in 
clinical studies (36-38). In the present study, we found that 4-n-butylresorcinol 
inhibits tyrosinase in intact cells more effectively than in cell lysates, 
suggesting that it inhibits tyrosinase by another mechanism in addition to direct 
inhibition of enzyme activity. QRT-PCR and western blot analysis showed that 
treatment with 4-n-butylresorcinol had no effect on mRNA levels of tyrosinase, 
but decreased its protein levels in a tyrosinase-specific manner in B16F10 cells. 
Therefore, we attempted to elucidate the mechanism through which 4-n-
butylresorcinol may influence the protein level of tyrosinase. Experiments 
using glycosidases and inhibitors for proteolytic enzymes revealed that 4-n-
butylresorcinol showed no effect on glycosylation processing or trafficking to 
melanosome, but accelerated proteasomal and lysosomal degradation. 
Moreover, we found that increased ubiquitination of tyrosinase by 4-n-
butylresorcinol is associated with activation of p38 MAPK. Our results indicate 
that 4-n-butylresorcinol reduces the total amount of tyrosinase probably 
through p38 activation. To our knowledge, enhancing proteolytic degradation 
is a new mechanism for 4-n-butylresorcinol to inhibit tyrosinase.
The protein level of tyrosinase in melanocytes is regulated by the balance 
between its synthesis and degradation. De novo synthesized tyrosinase is 
glycosylated and matured in the ER and Golgi, respectively, and transported to 
melanosome (41). Aberration of glycosylation resulted in ER retention of 
tyrosinase that leads to proteolysis by proteasome, which is known as ER-
associated degradation (ERAD) (25-27). In addition, mature forms of 
tyrosinase are also degraded by ERAD via retrograde transport to the ER or by 
the endosomal/lysosomal system in an ubiquitination-independent manner (22, 
49). Our results showed that the effect of 4-n-butylresorcinol on the protein 
level of tyrosinase was not associated with maturation processing, but with 
enhanced proteolytic enzyme activities (Fig. 1-8). Considering the quality
control function of both proteasomal and lysosomal systems by removing 
misfolded or unfolded proteins, these findings suggest that the binding of 4-n-
butylresorcinol may induce the unfolding of mature tyrosinase, thereby 
increasing proteolytic degradation of tyrosinase. In supporting this mechanism, 
we have shown that 4-n-butylresorcinol reduces the protein level of tyrosinase, 
but not of TRP-1. As revealed in a previous report, 4-n-butylresorcinol has more 
than two-fold higher binding affinity for tyrosinase than TRP-1 (10). Therefore, 
4-n-butylresorcinol more effectively destabilizes tyrosinase than TRP-1, 
leading to unfolding of tyrosinase.
A number of agents are known to inhibit tyrosinase by accelerating its 
degradation, including linoleic acid, 25-hydroxycholesterol, 12-O-
tetradecanoylphorbol-13-acetate (TPA), -dihydroxy-5,5-dipropyl-biphenyl, 
phenylthiourea, and 1-phenyl-3-(2-thiazolyl)-2-thiourea (22, 23, 34, 35, 46). Of 
these, linoleic acid, TPA, and 1-phenyl-3-(2-thiazolyl)-2-thiourea enhance 
tyrosinase degradation in a proteasom e -dependent manner, whereas 25-
hydroxycholesterol and phenylthiourea enhance in a proteasome-independent, 
but endosom e/lysosom e-dependent manner. In addition, linoleic acid and 
phenylthiourea induces tyrosinase-specific degradation, with no effect on the 
protein level of TRP-1. As shown in the present study, 4-n-butylresorcinol 
enhances tyrosinase degradation in a proteasome- and endosome/lysosome-
dependent manner, and this effect on protein degradation is specific to 
tyrosinase. Interestingly, both 4-n-butylresorcinol and phenylthiourea are 
phenol derivatives and tyrosinase-specific inhibitors, but show different 
dependency for the tyrosinase degradation system. Therefore, it seems likely 
that selection of a degradation pathway for tyrosinase might be related to the
inhibition mechanism of each agent.
Melanin synthesis is stimulated by MSH secreted from keratinocytes and 
melanocytes in response to UV irradiation or skin inflammation (14). However, 
it also has been shown that melanin synthesis is inhibited by UV-induced 
inflammatory cytokines, such as IL-1, IL-6, TNF, and TGF through the 
reduction of both protein and mRNA levels of tyrosinase (17, 50). Intriguingly,
a recent study showed that p38 MAPK, one of downstream effector kinases 
activated by these cytokines, negatively regulates melanin synthesis through 
decreasing tyrosinase stability (51). Thus, these observations indicate that an 
increase of p38 MAPK phosphorylation is associated with the activation of 
ubiquitin-mediated proteasomal degradation. We have demonstrated that the 
phosphorylation level of p38 MAPK is increased in 4-n-butylresorcinol-treated 
cells, suggesting that an increase of unfolded tyrosinase might activate p38 
MAPK, though a  causal relationship between protein stability and p38 
phosphorylation remains to be determined.
Finally, we compared the in vivo whitening efficacy of 4-n-butylresorcinol 
using an animal model. In our experiment, 4-n-butylresorcinol almost 
completely blocked UVB-induced melanin deposition and demonstrated more 
potent inhibitory activity than arbutin which is commercially used for anti-
melanogenic purposes. Although, arbutin showed a slight, but not significant 
decrement of melanin content in the skin, which may have been attributed to 
our small sample size (n=3). Nevertheless, since 4-n-butylresorcinol exhibited 
a significant decrement of melanin content in contrast to arbutin, it may be 
concluded that it is a more potent whitening agent than arbutin. 
In summary, 4-n-butylresorcinol is known to inhibit tyrosinase through 
competitive binding to its active site, and has been used as an anti-melanogenic 
agent. In this study, we reported a new mechanism by which 4-n-butylresorcinol 
inhibits melanin synthesis, and these findings may contribute to the 
development of an effective 4-n-butylresorcinol derivative.
Figure 1-8. Action mechanism of 4-n-butylresorcinol. Schematic model 
shows that 4-n-butylresorcinol affects ubiquitination of tyrosinase which leads 
proteasomal and endosomal/lysosomal degradation of tyrosinase.
* This study is published in International Journal of Cosmetic Science 
(2016) except for animal study.
CHAPTER 2
Transglutaminase 2 mediates UV-
induced skin inflammation by 
enhancing inflammatory cytokine 
production
2.1 INTRODUCTION
Transglutaminases (TGs) are a calcium-dependent enzyme family that 
produces crosslinked, polyaminated, or deamidated proteins by catalyzing the 
acyl-transfer reaction between glutamine and lysine residues of substrate 
proteins or polyamines (Fig. 2-1) (52, 53). Several proteins are crosslinked by 
TGs, such as loricrin, involucrin, cystatin A, filaggrin, trichohyalin, small 
proline-rich proteins, and keratins, which are components of the cornified 
envelope (CE), a barrier structure found in terminally differentiated 
keratinocytes (54). In the skin, 6 isozymes among 9 members of TG family are 
expressed, TG1–TG5 and factor XIIIa (55). Since TG isozymes share a 
common active-site structure and catalytic mechanism, isozyme-specific 
functions in the skin have been elucidated only by using isozyme-null mice and 
genetic analyses of congenital skin diseases.
TG1-null mice displayed defective CE formation in their stratum corneum 
and impaired skin barrier function leading to death within 4–5 h after birth due 
to dehydration (56). Moreover, TG1 mutations are the most common cause of 
autosomal recessive congenital ichthyosis in humans (57), indicating that 
crosslinking activity of TG1 plays a crucial role in epidermal barrier formation. 
Mice lacking TG3 showed thinner hair with markedly decreased crosslinking 
of hair proteins (58), and showed increased contact hypersensitivity elicited by 
FITC sensitization (59) and increased apoptosis induced by UV radiation (60). 
Mutations in TG3 have been associated with uncombable hair syndrome (61),
indicating that TG3 contributes to hair development as well as CE formation. 
TG5 is expressed in the upper layer of the human epidermis (54, 62), and TG5 
mutations cause acral peeling skin syndrome in humans (63), indicating the role 
of TG5 in cell to cell adhesion in the uppermost layer of epidermis. TG4 is 
expressed in glandular epithelia but not in epidermal keratinocytes, and TG4-
deficient mice showed no altered skin phenotypes (64). Factor XIIIa-deficient 
mice showed delayed and defective wound healing, indicating that the 
crosslinking activity of factor XIIIa plays a role in wound repair and remodeling 
(65). Unlike these TG isozymes, TG2-null mice showed no obvious altered skin 
phenotypes, despite its expression in epidermal keratinocytes (66). Moreover, 
there is no report of human skin disease associated with TG2. Thus, the role of 
TG2 in skin pathophysiology remains unknown.
UV irradiation causes acute inflammatory responses in the skin by inducing 
synthesis and release of proinflammatory cytokines, such as tumor necrosis 
factor- (TNF- and IL-6, from keratinocytes (5). Mechanistically, UV 
radiation generates reactive oxygen species (ROS) and DNA damage in 
keratinocytes, which activate the NF-B signaling pathway responsible for 
cytokine release (67, 68). However, the mechanism linking UV radiation with 
the activation of NF-B signaling remains unclear. Previously, we showed that 
intracellular TG2 is normally inactive, but activated under various stress 
conditions, including UV radiation, oxidative stress, hypoxia, and DNA 
damage, through mobilization of calcium (69-73). In cultured cells, stress-
induced TG2 activation results in enhancement of cell survival by crosslinking 
IB and caspase-3 (70, 74). In mouse models, activation of TG2 is reportedly 
involved in the development of cataract formation, tissue injury-induced lung 
fibrosis, and resistance to cancer chemotherapy by aberrantly increasing 
crosslinked proteins (52). These findings indicate that TG2 functions as a stress 
responsive enzyme, modulating cellular functions through modification of 
various substrate proteins (71).
Herein, we determined whether TG2 mediated inflammatory responses in 
UV-exposed skin, and showed that UV-induced TG2 activation is crucial for 
NF-B-dependent expression of proinflammatory cytokines. In this process, 
PLC/IP3/IP3R-mediated ER calcium release acts as an upstream signal for 
activation of TG2. These results indicate that TG2 is a critical regulator that 
mediates acute cutaneous inflammation in response to UV radiation.
Figure 2-1. Catalytic reactions by TGs. The thiol group located in the cysteine 
residue of the activated TG forms intermediate with !-carboxamide group of 
the glutamine residue. This intermediate reacts with lysine residue of the other 
protein (corsslinking) or primary amine (transamidation) or water molecule 
(deamidation). Modified image from the reference (53). 
2.2 MATERIALS AND METHODS
2.2.1 Mice
TG2-/- mice (66) were backcrossed 12 times on C57BL/6J background. Female 
WT and TG2-/- littermates (8-week-old) were used for all experiments. All mice 
were bled and kept in our animal facility at Seoul National University College 
of Medicine, Seoul, South Korea, under standard conditions (22 ± 1°C, 55 ± 5 % 
humidity, 12-h light and 12-h dark cycle). Animal experiments were approved 
by the Seoul National University Institutional Animal Care and Use Committee 
(IACUC No. SNU-130103-1-5). The dorsal skin was shaved and chemically 
depilated by Veet Cream (Oxy-Reckitt Benskiser, Slough, UK) 48 h before UV 
irradiation. 
2.2.2 Immunohistochemical analysis
Mouse skin tissues were fixed in 4% paraformaldehyde for 24 h, embedded in 
paraffin, and processed to get at 4 m thick sections for hematoxylin & eosin 
staining or immunohistochemical analysis. The sections were dewaxed in 
xylene (Junsei Chemical Co.,Ltd., Tokyo, Japan), unmasked with heat mediated 
antigen retrieval EDTA (pH 9), and incubated in 0.3% H2O2 in methanol for 30 
min at room temperature to eliminate endogenous peroxidase activity. The 
sections were then blocked for 60 min at room temperature in blocking serum 
in PBS, incubated in anti-TG2 polyclonal antibody (Thermo Fisher Scientific 
Inc., Rockford, IL, USA, RB-060-P) or primary antibody rabbit anti-CD11b 
(Abcam, Cambridge, MA, USA, ab133357), and equilibrated at 4°C overnight. 
The next day, sections were incubated in each biotinylated secondary antibody 
(secondary and blocking serum in PBS) for 30 min at room temperature. The 
secondary antibody was visualized using Vectastain ABC Elite Reagent (Vector 
Laboratories Inc., Burlingame, CA, USA) and 3,3'-diaminobenzidine (Dako, 
Denmark) according to the manufacturer's instructions. TUNEL staining was 
carried out according to the manufacturer’s protocol in the ‘ApopTag 
Peroxidase In Situ Apoptosis Detection Kit’ manual (Chemicon International, 
Inc., MA, USA). Mayer’s Hematoxylin was used as a counterstain. Coverslips 
were mounted and sealed with Tissue Tek Glas Mounting Media (Sakura, 
Torrance, CA, USA). Bright-field imaging was performed using a Leica-
microscope (Leica Microsystems, Bensheim, Germany), and images were 
captured using Microscope Imaging Software (Leica Microsystems, Bensheim, 
Germany). For in situ TG2 activity assay in mice exposed to UV irradiation 
(200 mJ/cm2), BP (0.1 mg/g) was administered 5 h after irradiation by 
intraperitoneal injection. Mice were sacrificed 3 h later, and skin tissues were 
embedded in Tissue-TEK OCT compounds (Sakura, Torrance, CA, USA),
reacted with streptavidin-488 (Thermo Fisher Scientific Inc., Rockford, IL, 
USA) and visualized using a FluoView 1000 confocal microscope (Olympus, 
Tokyo, Japan).
2.2.3 Immunohistochemistry on cryosections
Mice were euthanized by CO2 asphyxiation. The skin was harvested, embedded
in Tissue-Tek OCT compound (Sakura Finetek, Inc., Torrance, CA, USA), and
snap-frozen in liquid nitrogen. Frozen sections (10 m) were cut from OCT-
embedded tissues and fixed in cold acetone for 10 min and dried in air for 1 h.
The sections were blocked with H2O2 and subsequently treated with 10% goat
serum at room temperature for 20 min. They were then incubated with anti-
loricrin polyclonal antibody (Abcam, Cambridge, MA, USA, ab85679),
involucrin polyclonal antibody (Abcam, Cambridge, MA, USA, ab28057), and
filaggrin polyclonal antibody (Abcam, Cambridge, MA, USA, ab24584) at 4°C
for 18 h, followed by staining the proteins with Alexa Fluor 488-conjugated
goat anti-rabbit IgG (H+L) secondary antibody (Molecular Probes, Inc.,
Eugene, OR, USA) in accordance with the manufacturer’s instructions. The
sections were mounted with fluorescent mounting medium (Dako North
America, Inc., Carpinteria, CA, USA) and observed using a FluoView 1000
confocal microscope (Olympus, Tokyo, Japan).
2.2.4 Cell culture 
HaCaT cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM, 
Welgene, Gyeongsan, South Korea) containing 10% heat-inactivated fetal 
bovine serum (Hyclone, Logan, UT, UK), 100 U/mL of penicillin, and 100 
g/mL of streptomycin sulfate (Gibco, Carlsbad, CA, USA) under 5% CO2 at 
37°C. The TG2-deficient HaCaT cell line was generated by transfection with 
TG2 CRISPR/Cas9 vector (Santa Cruz Biotechnologies, Santa Cruz, CA, USA) 
and sorted by FACS. For generating short hairpin RNA (shRNA) expressing 
vectors, the following forward and reverse oligonucleotides were annealed in 
annealing buffer (100 nM Tris, pH 7.5, 1 M NaCl, 1 Mm EDTA) by heating the 
mixture at 100°C for 5 min and cooling to room temperature.
The annealed oligos were ligated into linearized pSuper plasmid (75) by 
HindIII and BglII enzyme digestion. The shRNA HaCaT cell lines were 
generated by co-transfection with pcDNA3 and pSuperGFP or pSuperTG2 
vector. HaCaT cells over-expressing TG2WT or TG2C277S were generated by 
transfection with WT or C277S mutant cDNA in pcDNA vector, respectively. 
All cells were selected with G418 (1 mg/mL, Sigma-Aldrich, St Louis, MO, 
USA) for 1 week. All cell lines were regularly tested to exclude mycoplasma 
contamination.
MNEKs were prepared from neonatal skin as previously described with 
minor modifications (76). Briefly, mice were euthanized with CO2 two days 
after birth. Mice were washed twice with betadine and then rinsed with 
phosphate buffered saline (PBS). The skin of neonates was removed and soaked 
in PluriSTEM™ Dispase-II solution (Merck Millipore, Darmstadt, Germany) 
for 12 h at 4°C. The skin was then separated to epidermis and dermis. The 
epidermal layer was incubated in 1 mL of TrypLE™ (Gibco, Grand Island, NY, 
USA) for 10 min at 37°C, then 1 mL of fetal bovine serum was added to 

















by centrifugation for 3 min at 1 000 x g at room temperature. The cell pellet 
was resuspended in keratinocyte proliferation media (1:1 mixture of KGM-
Gold and calcium free KGM-Gold kit media, Lonza, Lyon, France). MNEKs 
were used at passage 1.
2.2.5 UV irradiation 
G20T10E UVB lamp (Sankyo, Denki, Japan) was used for UV irradiation. 
UVB was measured using a UV light meter, UV-340A (Lutron Electronic 
Enterprise Co. LTD, Taipei, Taiwan). Cells and mice were exposed to a single 
dose of UVB radiation (10 mJ/cm2 for cells and 200 mJ/cm2 for mice). Cells in 
a 6-well plate were washed twice with PBS after removal of culture media, 500 
L PBS was added, and they were exposed to UVB radiation. 
2.2.6 Western blot analysis 
Sample preparation and SDS-PAGE were performed as previously described 
(35). The following primary antibodies were used: anti-"-actin (Sigma-Aldrich, 
St Louis, MO, USA, A5441), TG2 (77), p65 (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA, sc-8008), p-p65Ser536 (Cell Signaling Technology, Beverly, MA, 
USA, #3031), IB(Cell Signaling Technology, Beverly, MA, USA, sc-847). 
After reaction with horseradish peroxidase-conjugated secondary antibody 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-2004 or sc-2005), 
immunoreactive proteins were visualized by SuperSignal™ West Pico 
Chemiluminescent Substrate (Thermo Fisher Scientific Inc., Rockford, IL, 
USA). The bands were quantified using ImageJ (http://rsb.info.nih.gov/ij/).
2.2.7 QRT-PCR
Total RNA extraction and QRT-PCR were carried out using a CFX96TM Real-
Time system (Bio-Rad, Hercules, CA, USA) as previously described (78). The 
following specific primers were used.
Levels of mRNA were estimated by the 2- method and normalized to 
GAPDH or 36B4 levels.
2.2.8 Cytometric bead array (CBA) 
Secreted human TNF-IL-6, and -8 protein levels were measured by BD CBA 
(Thermo Fisher Scientific Inc.). Briefly, 4.5 x 105 HaCaT cells were seeded on 
6-well plates and incubated for 24 h. Then, culture medium was collected 6 h 
after UVB irradiation and analyzed according to the manufacturer’s
instructions. The MAGPIX Multiplexing System (Komabiotech, Seoul, Korea) 
was used to measure the protein levels of mouse IL-6 and TNF-














2.2.9 Luciferase reporter assay 
HaCaT cells and MNEKs were co-transfected with the @B-luciferase construct 
and pRL-TK vector as an internal control. Luciferase reporter activity was 
measured by a luciferase assay kit (Promega, Madison, WI, USA) 9 h after 
UVB irradiation.
2.2.10 in situ TG activity assay 
Six h after UVB irradiation, HaCaT cells were incubated with 1 mM EZ-link 
Pentylamine-Biotin (BP) (Thermo Fisher Scientific Inc., Rockford, IL, USA) 
as TG2 substrate in serum-free DMEM for 1 h. These cells were subjected to 
in situ TG activity assay as previously described (70).
2.2.11 Statistical analysis 
Statistical evaluations were performed with GraphPad Prism 5.0 statistical 
software (GraphPad Software, La Jolla, CA, USA) using Student’s t-test, or 
one-way or two-way ANOVA. P<0.05 was considered statistically significant. 
All error bars represent mean ± SEM. The data are representative of at least 3 
independent experiments.
2.3 RESULTS
2.3.1 TG2-deficient mice show reduced UV-induced skin 
inflammation
The crosslinking activity of TG1 and TG3 is crucial for CE formation during 
terminal differentiation of epidermal keratinocytes (54). To test whether TG2 is 
also involved in this process, we examined the skin barrier function of TG2-/-
mice. In wild-type (WT) mice, TG2 is expressed in all epidermal layers (Fig. 
2-2A). Histochemical staining of skin sections showed no differences between 
WT and TG2-/- mice in gross structure of the skin and expression of 
differentiation markers, such as loricrin, involucrin, and filaggrin in epidermal 
keratinocytes (Fig. 2-2A and B). Functional evaluation of skin permeability 
with toluidine blue staining revealed no difference between WT and TG2-/- mice 
(Fig. 2-2C). These results indicate that TG2 activity is not required for
differentiation or CE formation of epidermal keratinocytes.
TG2 is activated under various ROS-producing conditions, including UV 
irradiation (72). To determine whether TG2 is involved in UV-induced skin 
inflammation, we compared the effects of UV irradiation on the skin of WT and 
TG2-/- mice. After 48 h of UVB irradiation, TG2-/- mice showed reduced skin 
redness (Fig. 2-2D), significantly decreased swelling of the skin (Fig. 2-2E), 
reduced infiltration of immune cells to the UV-irradiated skin (Fig. 2-2F and 
G), reduced vasodilation in UV-irradiated lesions (Fig. 2-2I) compared with 
those of WT littermates. On the other hand, UV-irradiated WT and TG2-/- mice 
exhibited no significant difference in the number of TUNEL-positive skin cells 
(Fig. 2-2H), indicating that TG2 may be not involved in UV-induced skin cell 
apoptosis. These skin phenotypes of TG2-/- mice suggest a causal role of TG2 
in UV-induced acute inflammation.
Figure 2-2. TG2-/- mice exhibit reduced skin inflammation in response to 
UV irradiation without any alterations for keratinocyte differentiation and 
skin barrier function. (A) Histology of skin from WT and TG2-/- littermates 
(8-week-old, female). Skin sections were stained with anti-TG2 antibody and 
hematoxylin & eosin (H&E). (B) Skin sections prepared from WT and TG2-/-
neonates were immunostained with antibodies specific for loricrin, involucrin, 
and filaggrin. DAPI staining was used for localization of nuclei. Scale bar, 50 
m. (C) WT and TG2-/- neonates (birth day 0) or embryos (E15.5) were stained 
with toluidine blue. (D) Representative photographs of mice skin after 48 h of 
UV exposure (200 mJ/cm2 UVB). (E) Skin thickness measured by caliper at 
indicated times. Data are shown as mean ± SEM. (F-H) Histology and 
immunohistochemistry of skin from WT and TG2-/- littermates after 48 h of UV 
irradiation (200 mJ/cm2 UVB), skin sections were stained with H&E (F), 
CD11b (G), and TUNEL (H). (I) Vasculature of the UV-irradiated skin after 96 
h of UV-exposure. Scale bars, 100 m. *, P<0.05; **, P<0.01; ***, P<0.001.
2.3.2 TG2 mediates UV-induced production of 
inflammatory cytokines in keratinocytes
UV irradiation stimulates the production and release of inflammatory cytokines 
in epidermal keratinocytes, which elicits skin inflammation. To test whether 
TG2 mediates UV-induced cytokine production, we compared the ability of WT 
and TG2-/- mice to produce inflammatory cytokines in response to UV 
irradiation. In the UV-exposed skin from WT mice, there was a 30- and 6-fold 
increase in the mRNA levels of TNF-and IL-6, respectively, whereas there 
was no change in the expression levels of both cytokines in the skin of TG2-/-
mice (Fig. 2-3A). MAGPIX Multiplexing revealed that protein levels of both 
TNF-and IL-6 were significantly reduced in TG2-/- compared to those in the 
skin of WT mice in response to UV irradiation (Fig. 2-3B). To confirm the role 
of TG2 in keratinocytes, we prepared mouse neonatal epidermal keratinocytes 
(MNEKs) and examined the TNF-and IL-6 expression levels. MNEKs from 
TG2-/- mice showed significantly reduced levels of TNF- and IL-6 mRNA 
after UVB exposure compared with those from WT mice (Fig. 2-3C).
To test the role of TG2 in human keratinocytes, we generated TG2-/- and 
knockdown HaCaT cell lines by using the CRISPR-Cas9 system and small 
hairpin RNA (shRNA) transfection, respectively, and compared the levels of 
cytokine expression. In control HaCaT cells, mRNA levels of TNF-IL-6, and 
IL-8 rapidly increased after UV irradiation, remained constant for 2–4 h, and 
decreased thereafter to basal levels. In contrast, in TG2-/- and knockdown 
HaCaT cells, mRNA levels were significantly suppressed (Fig. 2-3D). The 
protein levels of TNF- IL-6, and IL-8 secreted from UV-irradiated HaCaT 
cells were also significantly reduced in TG2-/- and knockdown cells (Fig. 2-3E). 
These results indicate that UV irradiation induces the production of 
inflammatory cytokines through regulation of TG2 in epidermal keratinocytes.
Figure 2-3. TG2 is required for expression of inflammatory cytokines in 
UV-irradiated keratinocytes. (A and B) Skin tissues were obtained from WT 
and TG2-/- littermates after 48 h of UV irradiation (200 mJ/cm2). Levels of 
mRNA (A) and protein (B) for mouse IL-6 and TNF- were determined by 
QRT-PCR and MAGPIX Multiplexing assay, respectively. (C) Primary mouse 
keratinocytes from WT and TG2-/- littermates were cultured and exposed to UV 
irradiation (10 mJ/cm2). After 6 h, mRNA levels of mIL-6 and mTNF-were 
determined by QRT-PCR (n = 3). (D, E) TG2-deficient or TG2-knock down 
HaCaT cells exposed to UV irradiation (10 mJ/cm2). After 6 h, levels of mRNA 
(D, n = 3) and secreted protein (E, n = 3) for TNF- IL-6, and IL-8 were 
measured by QRT-PCR and by CBA method, respectively. All data are 
represented as mean ± SEM. *, P<0.05; **, P<0.01; ***, P<0.001.
2.3.3 UV irradiation increases TG2 activity but not its 
protein level
To gain evidence that TG2 is regulated by UV irradiation, we monitored the 
TG2 protein level and intracellular transamidation activity in UV-exposed 
HaCaT cells. Western blot analysis showed that there were no changes in the 
protein level of TG2 for 12 h after UV irradiation (Fig. 2-4A), even with 
increased dosage (Fig. 2-4B). Moreover, the mRNA levels of TG2, were not 
affected by UV irradiation (Fig. 2-4C). By contrast, UV irradiation induced a 
time- (Fig. 2-4A) and dose-dependent (Fig. 2-4B) increase of in situ TG activity, 
which paralleled mRNA levels of TNF-IL-6, and IL-8 in a time-dependent 
(Fig. 2-4D) and dose-dependent manner (Fig. 2-4E), indicating that UV-
induced cytokine production is correlated with in situ TG activity but not with 
TG2 protein level.
In addition to TG2, TG1, 3, and 5 are also expressed in epidermal 
keratinocytes (54), and the current TG assay method is not able to discriminate 
TG isozymes. To test whether UV irradiation activates TG2 only, we compared 
in situ TG activity in the skin of TG2-/- mice with that of WT mice. TG2-/- mice 
showed no increase in TG activity in the epidermis in response to UV 
irradiation, whereas WT mice exhibited substantially increased TG activity (Fig. 
2-4F). Similar results were observed in the TG2-deficient HaCaT cell line (Fig. 
2-4G), indicating that an increase in in situ TG activity can be attributed to UV-
induced TG2 activation.   
To confirm these results, we examined the effect of KCC009, an inhibitor 
of TG (79), on UV-induced cytokine expression. In HaCaT cells exposed to UV 
irradiation, KCC009 treatment significantly suppressed in situ TG activity (Fig. 
2-5A and B), and concomitantly reduced the mRNA (Fig. 2-5C) and protein 
levels of TNF-IL-6, and IL-8 compared with control cells (Fig. 2-5D). To 
further confirm TG2-specific activation by UV irradiation, we established 
HaCaT cell lines overexpressing WT TG2 (TG2WT) or active-site mutant of 
TG2 (TG2C277S). When these cells were exposed to UV irradiation, in situ TG 
activity was increased in proportion to TG2 protein levels. By contrast, HaCaT 
cells expressing TG2C277S failed to increase in situ TG activity (Fig. 2-5E), 
mRNA levels (Fig. 2-4F), and protein levels of proinflammatory cytokines 
compared with cells overexpressing TG2WT (Fig. 2-5G). These results indicate 
that UV irradiation promotes cytokine production through TG2 activation, but 
not through upregulation of TG2 expression.
Figure 2-4. UV irradiation activates keratinocyte TG2. (A and B) Levels of 
TG2 protein and in situ TG activity in HaCaT cells were determined by Western 
blot analysis and biotinylated pentylamine (BP) incorporation assay, 
respectively. HaCaT cells were exposed to UV irradiation (A, 10 mJ/cm2, n = 
4; B, doses indicated, n = 4) and harvested at the time indicated (A) or after 6 h 
of UV irradiation (B). (C) . HaCaT cells were exposed to UV irradiation (10 
mJ/cm2), and mRNA levels of TG1, TG2, TG3, and TG5 were determined by 
QRT-PCR (n = 3). (D and E) mRNA levels of TNF- IL-6, and IL-8 were 
determined by QRT-PCR in HaCaT cells exposed to UV irradiation as (A) and 
(B) (n = 3). (F) in situ TG activity in skin from UV-irradiated WT and TG2-/-
littermates (n = 3). (G) in situ TG activity in TG2-deficient (Cas9–TG2) and 
TG2-knock down (shTG2) HaCaT cells after 6 h of UV irradiation (10 mJ/cm2). 
All data are represented as mean ± SEM. *, P<0.05; **, P<0.01; ***, P<0.001.
Figure 2-5. TG inhibition suppresses the production of cytokines in UV-
irradiated keratinocytes. (A and B) HaCaT cells were pretreated with 
KCC009 (250 M) or vehicle (Vhcl) 1 h before UV irradiation (10 mJ/cm2). 
Cells were incubated for 6 h after UV irradiation in the same media. in situ TG 
activity was measured by BP incorporation assay (A, n = 3) and visualized by 
confocal microscopy (B). Scale bars, 50 m. (C and D) Levels of mRNA (C, n 
= 3) and proteins (D, n = 3) for TNF- IL-6, and IL-8 were measured in 
KCC009-pretreated and UV-irradiated HaCaT cells at the times indicated (C) 
or 6 h after UV irradiation (D). (E) Levels of TG2 protein and in situ TG activity 
were measured in HaCaT cell lines expressing pcDNA3, WT (TG2WT), or 
active-site mutant TG2 (TG2C277S) established by transfection and selection (n 
= 4). (F and G) Levels of mRNA (F, n = 4) and proteins (G, n = 4) for TNF-
IL-6, and IL-8 were measured in HaCaT cell lines expressing pcDNA3, WT 
(TG2WT) or active-site mutant TG2 (TG2C277S) at 6 h after UV irradiation. All 
data are represented as mean ± SEM. *, P<0.05; **, P<0.01; ***, P<0.001.
2.3.4 UV irradiation activates TG2 through endoplasmic 
reticulum (ER) calcium release
We next investigated the mechanism by which UV irradiation activates TG2 in 
epidermal keratinocytes. Since TG2 is a calcium-dependent enzyme, we 
considered the role of calcium in activating TG2 in UV-irradiated keratinocytes. 
UV irradiation increases cytosolic Ca2+, which is released from the ER through 
activation of the PLC-IP3 signaling pathway (80). To determine whether PLC 
activation is required for UV-induced increase of TG2 activity, we examined 
the effect of U73122, a pan-PLC inhibitor, on in situ TG activity. In HaCaT 
cells exposed to UV irradiation, pretreatment with U73122 suppressed in situ
TG activity, and mRNA expression of TNF- IL-6, and IL-8, whereas 
pretreatment with its inactive analogue U73343 showed no effect (Fig. 2-6A 
and B). Treatment with 2-aminoethyl diphenylborinate, an IP3R inhibitor, also 
exhibited suppressed in situ TG activity and cytokine mRNA expression (Fig. 
2-6C and D). To confirm the role of ER calcium in activating TG2, we evaluated 
the effect of thapsigargin treatment in HaCaT cells, which increased in situ TG 
activity and mRNA levels of inflammatory cytokines (Fig. 2-6E and F). These 
results indicate that TG2 is activated by UV-induced release of ER calcium 
through the PLC-IP3 signaling pathway.
Figure 2-6. UV-induced release of ER calcium is responsible for TG2 
activation. (A-D) HaCaT cells were pretreated with 20 M U73122 or U73343 
(A and B, n = 3) and with 100 M 2-aminoethyl diphenylborinate (2-APB) (C 
and D, n = 3), and then exposed to UV irradiation (10 mJ/cm2). After 6 h, levels 
of in situ TG activity and mRNA for TNF-IL-6, and IL-8 were measured by 
BP incorporation assay and QRT-PCR, respectively. (E and F) Effect of 
thapsigargin (500 nM) on in situ TG activity in HaCaT cells (E, n = 3) and 
expression of cytokines (F, n = 3) or in primary epidermal keratinocytes 
prepared from WT and TG2-/- littermates. All data are represented as mean ± 
SEM. *, P<0.05; **, P<0.01; ***, P<0.001.
2.3.5 Activation of TG2 enhances NF-B transcriptional 
activity
The NF-B signaling pathway plays a major role in the production of 
proinflammatory cytokines in response to UV irradiation (81), and TG2 is 
known to activate NF-B signaling under oxidative stress; however, its 
molecular mechanism remains unclear (74, 82). To determine whether TG2 is 
involved in NF-B activation under UV-irradiated conditions, we compared the 
ability to promote transcriptional activity of NF-B in WT- and TG2-/--MNEKs 
transiently transfected with the @B-luciferase gene. TG2-/--MNEKs showed 
significantly reduced NF-B reporter activity compared with WT-MNEKs after 
UV irradiation (Fig. 2-7A). In HaCaT cells stably expressing @B-luciferase, 
treatment with KCC009 or U73122 significantly inhibited UV-induced reporter 
activity of NF-B (Fig. 2-7B and C), indicating that TG2 activity is required 
for UV-induced NF-B activation.
To further analyze TG2-mediated NF-B activation, we monitored the 
protein levels of IBand phosphorylated p65. Western blot analysis showed 
that IB levels were decreased after UV irradiation in a time-dependent 
manner in TG2 knockdown, KCC009-treated, and control HaCaT cells. By 
contrast, levels of phosphorylated p65 (p-p65Ser536) were increased in control 
HaCaT cells, but decreased in TG2 knockdown and KCC009-treated cells (Fig. 
2-7D and E), indicating that TG2 mediates NF-B activation not by inducing 
IBdegradation, but by promoting phosphorylation of p65 at Ser536. These 
results indicate that UV irradiation activates TG2 through the PLC-IP3 pathway, 
which activates NF-B signaling by promoting p65 phosphorylation, leading to 
increase in proinflammatory cytokine production.
Figure 2-7. TG2 enhances transcriptional activity of NF-B. (A-C) @B-
luciferase reporter activity was assessed in primary epidermal keratinocytes 
prepared from WT and TG2-/- littermates (A, n = 3), or HaCaT cells (B and C, 
n = 3) 9 h after UV irradiation (10 mJ/cm2). HaCaT cells were pretreated with 
[\M KCC009 (B), or with 20 M U73122 or U73343 (C) 1 h before UV 
irradiation. Luciferase activity was normalized with co-transfected Renilla
activity. Data are represented as mean ± SEM. *, P<0.05; **, P<0.01; ***,
P<0.001. (D and E) Lysates prepared from TG2 knockdown HaCaT cells (D) 
or HaCaT cells treated with 250 M KCC009 (E) were immunoblotted with 
antibodies specific for IB phosphorylated p65 at Ser536, p65, and TG2. 
Actin was used as a loading control. Arrowhead in the blot indicates a 
nonspecific band.
2.4 DISCUSSION
UV irradiation elicits a range of responses in the skin, including inflammatory 
and DNA damaging responses, which lead to the development of photoaging 
and skin cancer in chronically exposed skin (67). Of these, acute inflammatory 
reaction is mediated by UV-induced release of proinflammatory cytokines, such 
as TNF- IL-6, and IL-8. However, the signaling pathways responsible for 
cytokine production in UV-exposed keratinocytes have not been fully 
characterized. Herein, we show that keratinocyte TG2 is a critical mediator in 
UV-induced acute skin inflammation, based on a phenotype analysis of TG2-
deficient mice. Moreover, our results identify the PLC-IP3 pathway as an 
upstream pathway for UV-induced TG2 activation and the NF-B pathway as 
a downstream pathway for TG2-induced release of proinflammatory cytokines. 
Collectively, these results indicate that TG2 is an effector enzyme that regulates 
NF-B activity following UV irradiation in epidermal keratinocytes.
Skin barrier function and keratinization were impaired in autosomal 
recessive congenital ichthyosis 1 caused by TG1 mutation (56, 57), and skin 
barrier defects observed in TG3-/- mice caused the reduction of inflammatory 
threshold of skin exposed to UV irradiation (59). These observations indicate 
that the crosslinking activity of TG1 and TG3 in epidermal keratinocytes plays 
a critical role in the formation of the skin barrier, which in turn affects the 
inflammatory response to UV irradiation. In contrast, our data show that 
keratinization and skin barrier function were normal in TG2-/- mice. Consistent 
with these results, recent reports have shown no difference between TG1-/- and 
TG1/TG2 double knockout mice in the structure of the epidermal CE (83). Thus, 
our results indicate that the reduced inflammatory response of TG2-/- mice to 
UV irradiation is not attributable to change in barrier function.
Our results provide insight into the role of PLC signaling in skin 
inflammation. PLC regulates cellular functions through hydrolysis of PIP2 to 
DAG and IP3, which bind with IP3R on the ER membrane, leading to ER 
calcium release into the cytosol (84). In keratinocytes, PLC is a known 
regulator of inflammation. PLC] knock-out mice exhibited reduced UV-
induced skin inflammation (85, 86), and reduced allergic contact 
hypersensitivity due to hampered expression of proinflammatory cytokines (87). 
Moreover, transgenic mice overexpressing PLC] in epidermal keratinocytes 
showed development of spontaneous skin inflammation (88). However, the 
pathway that mediates PLC-induced inflammation remains unknown. Our 
results demonstrate that TG2 is activated by increase in cytosolic calcium and 
it modulates NF-B activity, thus indicating a pathway linking PLC signaling 
with skin inflammation. UV irradiation is also known to induce ER stress, 
triggering unfolded protein response by release of ER calcium (80, 89).
Consistent with these findings, we showed that TG2 is activated by ER stress 
via oxidative stress-induced ER calcium release (71). Moreover, a recent report 
showed that TG2 crosslinks IP3R-1, thereby inhibiting ER calcium release (90).
This reaction might be a negative feedback mechanism to maintain intracellular 
calcium homeostasis and TG2 activity. These results imply that regulation of 
TG2 activity by ER calcium is a critical point of control in the inflammatory 
response to UV irradiation.
TG2 is a calcium-dependent enzyme, and it is known that the EC50 of [Ca2+]i
required for activating TG2 is approximately 100–500 M (91-95). At these 
calcium levels, TG isozymes expressed in epidermal keratinocytes, such as 
TG1 and TG3, can also be activated. Since it is not possible to evaluate TG 
isozyme-specific activity due to the lack of an effective assay method and 
isozyme-specific inhibitor, we used a genetic approach to assess UV-induced 
TG activation. Our results show that TG2 contributes > 90% of basal and 60% 
of UV-induced TG activity by comparison of in situ TG activity between WT 
and TG2-deficient HaCaT cells (Fig. 2-3G). Moreover, a majorly activated TG 
isotype in UV-irradiated mouse skin is TG2 in the upper layers of epidermis, 
where TG1 and TG3 are expressed, as well as in the lower layers of that by 
comparison of in situ TG activity between WT and TG2-/- mice (Fig. 2-3F). 
These results indicate that although TG1 and TG3 are also activated by UV 
irradiation, TG2 activation may account for most of the UV-induced increase 
of epidermal TG activity. In support of these data, proteolytic cleavage is 
required for TG1 and TG3 activation, in addition to increase in [Ca2+]i during 
terminal differentiation of keratinocytes (96, 97). Nevertheless, UV irradiation 
upregulates TG1 expression through the NF-B pathway (98), leading to 
restoration of damaged barrier function (99). TG3 has a protective role against 
photodamage, owing to its activity requirement in CE assembly (60). Thus, 
TG1 or TG3 inactivation might exacerbate UV-induced skin inflammation.
TG2 positively regulates NF-B signaling in various cancer cell lines. 
However, the substrate protein(s), whose function is altered by TG2-mediated 
modification, remains unidentified. Here, we tested two proposed mechanisms 
for activation of NF-B signaling. First, TG2 is known to activate NF-B
through crosslinking of IBwhich induces release and subsequent nuclear 
translocation of NF-B (74). However, our results show that the protein level 
of monomeric IBwas decreased by UV irradiation, even in TG2 knockdown, 
inhibitor-treated, and control HaCaT cells. Moreover, dimeric or multimeric 
forms of crosslinked IB were not observed in the same experimental 
conditions, indicating that IBcrosslinking did not occur in TG2-mediated 
NF-B activation. Second, TG2 reportedly facilitates nuclear translocation of 
NF-B, regardless of its enzymatic activity in breast cancer cells (82). In 
contrast to this report, our data show that expression of enzymatically inactive 
TG2 failed to increase expression of proinflammatory cytokines after UV 
irradiation, demonstrating that transamidation activity of TG2 is required for 
UV-induced NF-B activation. Instead, we show that p65Ser536 phosphorylation 
was increased, but decreased in TG2 knockdown or inhibitor treated cells after 
UV irradiation (Fig. 2-6D and E). Since Ser536 is phosphorylated by IKK (100),
and is a functionally important residue in regulating the transcriptional activity 
of p65 (101), our results imply that TG2 activates NF-B signaling by 
increasing p65Ser536 phosphorylation in UV-irradiated keratinocytes. However, 
there is no evidence that TG2 regulates kinase activity of IKKs. Moreover, it 
was reported that TG2 activates NF-B signaling in an IKK-independent 
manner (102). Thus, further investigation of the molecular mechanism by 
which TG2 regulates phosphorylation of p65Ser536 is needed.
In summary, we have shown that keratinocyte TG2 plays a pivotal role in 
mediating UV-induced skin inflammation. TG2 is activated by UV-induced ER 
calcium release through the PLC-IP3 signaling pathway, which in turn activates 
NF-B signaling, leading to increase in proinflammatory cytokine production 
(Fig. 2-7A). These findings suggest that inhibition of keratinocyte TG2 might 
be a useful strategy in preventing UV radiation-related skin disorders, such as 
photoaging and skin cancer, which occur with chronic exposure to UV 
irradiation.
Figure 2-8. Schematic representation of TG2-dependent UV-induced 
inflammation. UVB-induced activation of PLC facilitates release of calcium 
from ER to cytosol. The cytosolic increment of free calcium ions induces 
activation of TG2, followed by transcriptional activation of NF-B. Activated 
NF-B initiates transcription of target genes such as IL-6, IL-8 and TNF-
which are mediates skin inflammation.
* This study is published in Cell Death & Disease (2017).
CHAPTER 3
Transglutaminase 2 mediates UVB-
induced matrix metalloprotease-1, -3
and -13 expression in dermal fibroblasts
3.1 INTRODUCTION
Transglutaminases (TGs) constitute a large family of enzymes that are 
responsible for the posttranslational modification of proteins by catalyzing 
acyl-transfer reaction between substrate proteins and polyamines in calcium-
dependent fashion (52). Until now, nine members of the TG family proteins 
have been identified and six isozymes among the family are expressed in human 
skin including TG1-{[|}(55). 
TG1, TG3 and TG5 are enzymes playing crucial role in maintaining 
epidermal barrier by mediating crosslinking of various cornified envelope (CE) 
components including loricrin, envoplakin, periplakin, involucrin, small 
proline-rich proteins (SPRs), and lipids (54). TG1 is the most critical enzyme 
for normal epidermal barrier formation in mouse and human. TG1-null mice 
die from dehydration due to defective in CE formation within 4-5 h after birth 
(56). Additionally, TG1 mutations in human cause autosomal recessive 
congenital ichthyosis (57). Skin TG3 participates in crosslinking of hair 
proteins (58), FITC-induced hypersensitivity (59) and UV-induced apoptosis 
(60) in mouse, and uncombable hair syndrome in human (61), indicating TG3 
has roles in hair development as well as CE formation. TG5 mutations in human 
are associated with acral peeling syndrome (63), indicating TG5 regulates cell-
to-cell adhesion in epidermis. In }}|

||
is considered to be |  |} 	 
|	  -null mice 
showed impaired wound healing phenotype (65). Although TG4 is expressed in 
glandular epithelial cells, there are no reports on altered skin phenotype(s) of 
TG4-null mice. Unlike these isozymes, TG2-null mice showed normal skin 
phenotype (66). Previously, we showed that UV irradiation induces enzymatic 
activation of intracellular TG2 through the calcium mobilization (72, 103).
Additionally, TG2 activation is indispensable in UV-induced acute skin 
inflammation through mediating transcriptional activation of NF-B and 
following expression of inflammatory cytokine genes (103). Furthermore, 
Victoria et al. (104) reported that TG2 abundance and its activity in mediating
crosslinking of extracellular matrix (ECM) are crucial for pathogenesis of 
recessive dystrophic epidermolysis bullosa (RDEB). These results indicate that 
TG2 regulates skin homeostasis under pathogenic rather than normal condition.
Matrix metalloproteinases (MMPs) are a family of zinc-dependent 
endopeptidases that degrade various ECM components. At least 28 different 
types of MMPs have been discovered and they can be subdivided into several 
classes, based on their substrate specificities and structures (Table 3-1) (11).
MMPs play critical roles in tissue remodeling during pathophysiological 
processes, including developmental morphogenesis, angiogenesis, tissue repair, 
arthritis, tumor invasion and metastasis and skin aging. Human fibroblasts 
express several different types of MMPs including MMP-1 (collagenase), 
MMP-2 and -9 (gelatinase) and MMP-3 (stromelysin) following various 
stresses, such as UV, infrared radiation and heat shock (105-108). UV 
irradiation induces MMP-1, -3, and -9 expressions through activation of AP-1
and NF-B pathways (109, 110). In particular, MMP-1 is the most important 
MMP family proteins in maintaining ECM homeostasis of the skin since it is a 
major collagenolytic enzyme responsible for UV-damaged human skin (111). 
Herein, we determined whether TG2 mediates UV-induced human and 
mouse MMPs expressions, and showed that TG2-dependent NF-B activation 
is crucial in this process through cell culture and ex vivo skin culture model. 
These results suggest that TG2 is a critical regulator that mediates MMPs 
expressions and remodeling of the skin in response to UV radiation.
Table 3-1. Classification of human metalloproteinases (11).
MMP subgroups MMP number
Collagenase MMP-1, MMP-8, MMP-13
Gelaninase MMP-2, MMP-9
Stromelysins MMP-3, MMP-10, MMP-11
Matrilysins MMP-7, MMP-26
Membrane-type MMP-14, MMP-15, MMP-16, MMP-17, MMP-24, MMP-25
Other types MMP-12, MMP-19, MMP-20, MMP-21, MMP-22, MMP-23, MMP-28
3.2 MATERIALS AND METHODS
3.2.1 Cell culture and siRNA transfection
Human dermal fibroblasts (HDFs) were purchased form Gibco (Gibco, 
Carlsbad, CA, USA) and cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM, Welgene, Gyeongsan, South Korea) containing 10% heat-inactivated
fetal bovine serum (FBS, Hyclone, Logan, UT, UK), 100 U/mL of penicillin, 
and 100 g/mL of streptomycin sulfate (Gibco, Carlsbad, CA, USA) under 5% 
CO2 at 37°C. For siRNA transfection, 1 x 105 cells were plated on 6-well plate 
and incubated 24 h. GFP and TG2 siRNAs (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA, sc-45924, sc-37514) were transfected by using RNAiMAX 
(Invitrogen, NY, USA) in accordance with the manufacturer’s instruction. All 
experimental procedures were performed 24 h after siRNA transfection. HDFs 
were used under passage 8.
3.2.2 Isolation of mouse dermal fibroblasts and ex vivo skin 
culture
Mouse dermal fibroblasts (MDFs) were prepared from neonatal mice skin as 
previously described with minor modifications (76). Briefly, mice were 
euthanized with CO2 two days after birth and washed twice with betadine and 
then rinsed with phosphate buffered saline (PBS). After removing the skin from 
neonates, the skin was soaked in PluriSTEM™ Dispase-II solution (Merck 
Millipore, Darmstadt, Germany) for 12 h at 4°C. The skin was then separated 
to epidermis and dermis. The dermal layer was incubated in 1 mL of TrypLE™
(Gibco, Grand Island, NY, USA) for 50 min at 37°C, then 1 mL of FBS was 
added to inactivate TrypLE™. The dermal tissues were vortexed for 10 min 
followed by centrifugation for 3 min at 1000 x g at room temperature. The cell 
pellet was resuspended and cultured in DMEM containing 10% FBS and 1% 
penicillin-streptomycin. MDFs were used under passage 3.
For ex vivo culture, the skin removed from neonate mice was divided into 
four pieces and incubated in DMEM containing 0.1% FBS and 1% penicillin-
streptomycin for 24 h. Culture media changed (DMEM containing 10% FBS 
and 1% penicillin-streptomycin) after UVB irradiation and incubated as 
indicated times.
3.2.3 UV irradiation
G20T10E UVB lamp (Sankyo, Denki, Japan) was used for UV irradiation. To 
measure UVB, UV light meter, UV-340A (Lutron Electronic Enterprise Co. 
LTD, Taipei, Taiwan) was used. The cells and skins were exposed to a single 
dose of UVB radiation (10 mJ/cm2 for cells and 200 mJ/cm2 for skin). To 
irradiate cells, 3 x 105 cells were seeded on 6-well plate and incubated for 24 h.
The cells were washed twice with PBS after removal of culture media, 500 L
PBS was added to prevent dry, and they were exposed to UVB radiation. 
Cycloheximide (Sigma-Aldrich Co., St Louis, MO, USA) or MG132 (Sigma-
Aldrich Co., St Louis, MO, USA) were added to culture media according to the 
experimental conditions.
3.2.4 in situ TG activity assay
Six hours after UVB irradiation, HDFs were incubated with 1 mM EZ-link 
Pentylamine-Biotin (BP) (Thermo Fisher Scientific Inc., Rockford, IL, USA) 
in serum-free DMEM for 1 h. In situ TG activity was measured as previously 
described (70). 
3.2.5 Gelatin zymography
Since gelatin is a partial substrate of MMP-1 (117), MMP-1 activity can be 
measured by gelatin zymography. The culture media were collected after 48 h 
of UV irradiation and mixed with the same volume of 2X sample buffer (122 
mM pH7.4 Tris-HCl, 20% Glycerol, 4% SDS, 0.01% bromophenol blue). The 
mixture was loaded on 0.5% gelatin-acrylamide gel. After gel running, the gel 
was washed by 2.5% Triton X-100 solution for 20 min at room temperature 
with gentle agitation for two times then washed with distilled water. Then, the 
gel was incubated in incubation buffer (50 mM pH 7.4 Tris-HCl, 10 mM CaCl2,
10 nM ZnCl2, 0.01% NaN3) for 18 h at 37Enzymatic activity was visualized 
by coomassie staining and imaged by scanning the gel.
3.2.6. Cell in situ zymography
Cell in situ zymography was performed and quantified as previously described 
with minor modifications (112). Briefly, cells were incubated on the coverslip 
and then UVB irradiated. The cells were fixed by methanol for 15 min at -20
followed by incubation with 2 g/ml DQ™ 	| 	  	>
	
Scientific Inc., Rockford, IL, USA) at 37 for 1h. DQ™ 	|	

diluted with MMP reaction buffer (100 mM NaCl, 100 mM Tris-HCl pH7.5, 10 
mM CaCl2\M ZnCl, 0.05% Brij). After wash six times with 1X PBS, the 
coverslips were mounted on mounting medium (Dako North America, Inc., 
Carpinteria, CA, USA) and observed using a FluoView 1000 confocal 
microscope (Olympus, Tokyo, Japan). Corrected Total Cell Fluorescence 
(CTCF) was calculated using Image J software (http://rsb.info.nih.gov/ij/).
CTCF = Integrated density of selected cell – (Area of selected cell x Mean 
fluorescence of background)
3.2.7 Nuclear fractionation
The cells were seeded on 100 mm dishes between 95-100% confluency and 
incubated for 24 h. The cells were harvested by scraper and pelleted after UVB 
irradiation at indicated times. After removing supernatant, the pellets were 
gently mixed with 500 l hypotonic buffer (20 mM pH7.5 Tris-HCl, 10 mM 
NaCl, 3mM MgCl2 containing protease and phosphotase inhibitor cocktail) and 
incubated on ice for 15 min. Then, 21.5 l of 10% NP-40 was added to each 
samples then vigorously vortexed for 10 secs and centrifuged for 10 min at 
3,000 rpm,  The supernatant contains the cytoplasmic fraction. Nuclear 
pellets were lysed in 200 l cell extraction buffer (100 mM pH7.5 Tris-HCl, 2 
mM Na3VO4, 1 mM NaF, 100 mM NaCl, 1% Triton X-100, 10% glycerol, 1 
mM EDTA, 1 mM EGTA, 0.5% sodium deoxycholate, 20 mM Na4P2O7
containing protease and phosphatase inhibitor cocktail (Roche, Indianapolis, IN, 
USA)) followed by sonication and centrifuged for 30 min at 14,000 x g, 4
The supernatant contains the nuclear fraction. Each fractions were quantified 
by BCA method for western blotting.
3.2.8 Western blot analysis
Sample preparation and SDS-PAGE were performed as previously described 
(35). The following primary antibodies were used: anti-"-actin (Sigma-Aldrich, 
St Louis, MO, USA, A5441), TG2 (77), MMP-1 (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA, sc-8834), MMP-13 (Thermo Fisher Scientific Inc., 
Rockford, IL, USA, MS-827-P1), Collagen 1 (Abcam, Cambridge, MA, USA, 
ab88147), p65 (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-8008), p-
p65Ser276 (Abcam, Cambridge, MA, USA, ab106129), p-p65Ser468 (Cell 
Signaling Technology, Beverly, MA, USA, #3039), p-p65Ser536 (Cell Signaling 
Technology, Beverly, MA, USA, #3031), c-Jun (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA, sc-1694), phospho-c-JunSer63 (Cell Signaling Technology, 
Beverly, MA, USA, #2361), p38 (Santa Cruz Biotechnology, Santa Cruz, CA, 
USA, sc-728), phospho-p38Thr180/182 (Cell Signaling Technology, Beverly, MA, 
USA, #9211), COX-1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-
1752), Lamin B (Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-6216).
After reaction with horseradish peroxidase-conjugated secondary antibody 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA, sc-2004 or sc-2005), 
immunoreactive proteins were visualized by SuperSignal™ West Pico 
Chemiluminescent Substrate (Thermo Fisher Scientific Inc., Rockford, IL, 
USA). The bands were quantified by using ImageJ software 
(http://rsb.info.nih.gov/ij/).
3.2.9 QRT-PCR
Total RNA extraction and QRT-PCR were carried out using a CFX96TM Real-
Time system (Bio-Rad, Hercules, CA, USA) as previously described (78). The 
following specific primers were used
Relative mRNA expression was calculated by 2- method (40).
3.2.10 Luciferase reporter assay 
For human MMP1 promoter-luciferase, AP-1-luciferase and 3B-luciferase 
assay, MDFs were transfected with the human MMP1 promoter construct (113)
or 3xAP1pGL3 vector (Addgene #40342) or @B-luciferase construct, 
respectively. pRL-TK vector was co-transfected to normalize luciferase activity. 
Luciferase reporter activity was measured by a luciferase assay kit (Promega, 
Madison, WI, USA) in accordance with the manufacturer’s instruction. 










GraphPad Prism 5.0 statistical software (GraphPad Software, La Jolla, CA, 
USA) was used for statistical evaluations. Two-way ANOVA was conducted for 
evaluation. P<0.05 was considered statistically significant. All error bars 
represent mean ± SEM. 
3.3 RESULTS
3.3.1 UVB irradiation induces human MMP-1 and -3 and 
mouse MMP-13 expressions but not in TG2-deficient 
dermal fibroblast
In our previous studies we showed that UV induced ROS generation and 
increased cytosolic free calcium are critical factors for TG2 activation (72, 73).
It is an indispensable process for UV-induced acute skin inflammation through 
regulating inflammatory cytokine expression (103). Since UVB can penetrate 
into upper dermal layer of skin (114), it is plausible that UVB activates TG2 of 
dermal fibroblasts. However, there is no research on the role of TG2 in 
fibroblasts after UVB irradiation. 
MMPs are zinc-containing endopeptidases which mediate dermal 
remodeling through the degradation of broad range dermal matrix proteins 
(115). To investigate the role of TG2 in UV-induced dermal remodeling, we 
examined the TG2-dependent expressions of MMP proteins in human dermal 
fibroblasts (HDFs). HDFs treated with TG2 siRNA showed decreased level of
MMP-1 mRNA expression as well as MMP-3 after UVB irradiation (Fig. 3-
1A). Western blot analysis showed that increased MMP-1 secretion into the
culture media of control-siRNA-treated HDFs after UVB irradiation, whereas 
TG2-siRNA-treated cells did not (Fig. 3-1B). Next, we further examined the 
role of TG2 in the expressions of MMPs using primary neonatal mouse dermal 
fibroblasts (MDFs). MMP-13 mRNA level was measured since it is a main 
collagenase gene in mice (116). Similar with the data obtained from HDFs, 
MDFs obtained from TG2-/- mice failed to express MMP-13 mRNA as much as 
WT cells did (Fig. 3-1C). In addition, enzymatic activities of MMP-1 and 
MMP-13 were measured by zymography. As shown in Fig. 3-1D and E, it was 
observed that MMP-1 and MMP-13 activities decreased in TG2-siRNA-treated 
culture media and TG2-/- MDFs, respectively. Although we showed that TG2 is 
indispensable for expressing MMP proteins in the data above, it did not regulate
the expression of collagen1A1, a major ECM protein of dermis (Fig. 3-1A and 
B). These results suggest that TG2 is essential for regulating human MMP-1, -
3 and mouse MMP-13 expressions without affecting collagen gene expression.
Figure 3-1. Reduced MMP-1, -3 and -13 expression in TG2-deficient 
fibroblasts after UVB irradiation. siRNA (control or TG2) was transfected to 
HDFs. Twenty-four hours after transfection, the cells were irradiated by UVB 
(10 mJ/cm2). MMP-1, MMP-3 and collagen1A1 mRNA (A) and secreted 
protein (B) levels were measured 48 h after irradiation. Actin from un-
quantified lysate was used for loading control. (C) Mouse MMP-13 mRNA 
expression was measured 24 h after UV irradiation. (D) After 48 h of UV 
irradiation, culture media were collected and used for gelatin zymography at 
non-reducing condition. (E) MMP-13 activity was measured using DQ™
	| 	  Scale bar, 100 m. All data are represented as ± SEM. *,
P<0.05; **, P<0.01; ***, P<0.001, CTCF, corrected total cell fluorescence.
3.3.2 KCC009 treated fibroblasts show decreased MMP-1
and -3 expressions after UVB irradiation
Previously, we showed that enzymatic activity of TG2 is a more important 
factor than its protein level in UVB-mediated acute skin inflammation (103).
KCC009, an inhibitor of TG (79), was used to gain evidence for significance of 
enzymatic activity of TG2 in UV-mediated MMPs expressions. 
First, UV-induced transamidation activity of TG2 in fibroblasts was 
measured. UV-irradiated HDFs showed two to four fold increase of 
transamidation activity, whereas we observed the activity was comparable in 
KCC009-treated and TG2 siRNA-treated HDFs with un-irradiated cells (Fig. 
3-2A and B). In addition, KCC009-treated HDFs showed reduced MMP-1 and 
-3 mRNA expressions after UVB irradiation (Fig. 3-2C). As with its mRNA 
expression, there was reduced secretion of MMP-1 protein in the culture media 
of KCC009 treated HDFs (Fig.3-2D). Similar with TG2 siRNA treated HDFs, 
KCC009 treatment did not affect mRNA and protein level of collagen1A1 (Fig. 
3-2C and D). These data indicate that the enzymatic activity of TG2 is also a 
critical factor as much as its protein level.
Figure 3-2. KCC009 treatment decreases MMP-1 and -3 expression after 
UVB irradiation. HDFs were pre-treated with KCC009 (250 M) 1 h before 
UV irradiation (10 mJ/cm2). (A) In situ TG activity was measured by BP 
incorporation in KCC009-treated (A, right panel) or TG2 siRNA-treated (A, 
left panel) HDFs 6 h after UV irradiation. (B) In situ TG activity was visualized 
by confocal microscopy. Scale bar, 30 m. MMP-1, -3 and collagen1A1 mRNA 
(C) and protein levels (D) were measured 48 h after UV irradiation. All data are 
represented as ± SEM. **, P<0.01; ***, P<0.001. n.s., non-significant.
3.3.3 TG2 regulates MMP-1 expression at the
transcriptional level through NF-B rather than AP-1
pathway
MMPs can be regulated by transcription, inhibition of activated MMPs and 
activation of zymogen (118, 119). Fig. 3-1 and 3-2 show that TG2 regulates 
MMPs expressions at their transcriptional levels. To examine this, WT and 
TG2-/- MDFs were transiently transfected with human MMP-1 promoter. As 
shown in Fig. 3-3A, human MMP-1 promoter transfected WT MDFs showed 
about 1.5 times higher luciferase activity following UVB irradiation than un-
irradiated WT cells. However, luciferase activity did not change in TG2-/- MDF 
regardless of UV irradiation. Furthermore, TG2-/- cells showed one third lower 
luciferase activity than WT cells at un-irradiated condition. This data indicate 
that TG2 regulates MMP-1 expression at basal condition as well as UV-
irradiated situation.
It has been suggested that UV irradiation induces an excess generation of 
ROS such as singlet oxygen (1O2), superoxide anion (O2-), hydrogen peroxide 
(H2O2) and hydroxyl radicals (OH·) (120). ROS activates the mitogen-activated 
protein kinase (MAPK) family including extracellular signal-regulated kinases 
(ERKs), p38 and c-Jun NH2-terminal kinase (JNK). These proteins are 
upstream kinases for activating activator protein-1 (AP-1) transcription factor. 
AP-1 is a class of dimeric transcription factors, which is composed of Jun (c-
Jun, JunD, JunB), Fos (c-Fos, FosB, Fra-1, Fra-2), and ATF (ATF-2, ATFa) 
families (121). The heterodimeric form, made of c-Jun and c-Fos, is discovered 
most commonly in the cells. ERK stimulates the expression of c-Fos, whereas 
p38 and JNK regulate expression of c-Jun (11). Regulation of c-Jun protein 
level is a critical factor in AP-1 activity as c-Fos is constitutively expressed in
the cells (1). c-Jun protein level is important in regulating MMP transcription 
since most MMP gene promoters including MMP-1, MMP-3 and MMP-13 
contain AP-1 binding site (122, 123). For these reasons, the relationship 
between TG2 and AP-1 transcription factor was examined by measuring AP-1
promoter luciferase activity and c-Jun protein level. However, as shown in Fig. 
3-4A, we could not observe TG2-dependent changes of transcriptional activity 
of AP-1 in UV-irradiated WT and TG2-/- MDFs. Moreover, UV-irradiated HDFs 
and MDFs increased protein levels of c-Jun as well as p-c-JunSer63, which 
indicates increased transcriptional activity (124). On the other hand, there was 
no difference in the protein levels of c-Jun and p-c-JunSer63 between TG2-
siRNA-treated HDFs and TG2-/- MDFs, comparing to its control cells (Fig. 3-
4B).
Besides AP-1, NF-B is another transcription factor that regulates MMP-1, 
-3 and -13 expressions at transcriptional level (123, 125). In the previous study, 
we showed that UV irradiated keratinocytes have increased NF-B activity in 
accordance with increase of TG2 activity (103). Furthermore, several 
researches concluded that TG2 positively regulates NF-B activity (74, 82, 
103), yet the regulating mechanism is still not clear. This has raised the question
whether TG2-mediated NF-B activity has a role in UV-induced MMP 
expression. As shown in Fig. 3-4C, TG2-/- MPFs failed to increase @B-
luciferase activity after UVB irradiation, whereas UVB-irradiated WT MPFs 
showed about three times higher level of @B-luciferase activity than non-
irradiated cells. Next, we investigated nuclear translocation of p65, a subunit of 
NF-B, which indicates NF-B activity at the nucleus. We could not observe 
different nuclear translocation of p65 in TG2 knock-downed or inhibitor-treated 
cells comparing to the control cells. Instead, however, we observed increased 
p-p65Ser468 in the nucleus of TG2 abrogated cells, but there were no significant
changes in other phosphorylation sites. Ser468 residue of p65 is phosphorylated 
by GSK" and IKK" and known to negatively regulates NF-B function. (126, 
127). Functionally, this phosphorylation site is required for COMMD1-
dependent ubiquitination and target gene-specific proteasomal elimination of
p65 (128). That is, increased p-p65Ser468 is a sign of p65 degradation in the 
nucleus. However, this degradation effect can be masked by resynthesized p65, 
as only a small fraction of p65 undergoes proteasomal degradation. To prevent 
resynthesis of the degraded protein, cycloheximide (CHX) was administrated 
into the culture media after UV irradiation. In this experimental condition, 
reduced nuclear p65 protein level was observed in KCC009-treated HDFs (Fig. 
3-4E). These data imply that TG2 regulates transcriptional activity of NF-B 
through phosphorylation of p65 at Ser468, thereby inducing target gene specific 
elimination of p65 rather than modulating nuclear translocation of p65. In 
summary, TG2 regulates MMP-1, -3 and -13 expressions via NF-B activation 
rather than regulating AP-1 activity.
Figure 3-3. Human MMP-1 promoter activity in TG2-deficient MDFs after 
UVB irradiation. Human MMP1 activity was assessed in MDFs prepared from 
WT and TG2-/- littermates. MDFs were transfected with human MMP-1
promoter vector. After UV irradiation, the cells were incubated 24 h. Luciferase 
activity was normalized co-transfected Renilla activity. Data are represented as 
mean ± SEM. **, P<0.01; ***, P<0.001.
Figure 3-4. TG2 regulates NF-B but not AP-1 activity. (A) MDFs were 
transfected with 3xAP1pGL3 vector. The cells were incubated 12 or 24 h after 
UV irradiation. Luciferase activity was normalized by co-transfected Renilla
activity. (B) Six hours after UV irradiation, the cells were lysed and 
immunoblotted with indicated antibodies. As a loading control, actin was used. 
(C) @B-luciferase reporter activity was assessed 9 h after UVB irradiation (5 
mJ/cm2) in MDFs prepared from WT and TG2-/- littermates. Luciferase activity 
was normalized by co-transfected Renilla activity. (D) After 6 h of UV 
irradiation, the cells were separated into cytoplasm and nucleus. (E) After UV 
irradiation, the cells were incubated with 10 g/ml CHX for 6 h and then 
fractionated. The fractions were immunoblotted with the indicated antibodies. 
Cox-1 and LaminB were used as marker proteins for cytoplasm and nucleus, 
respectively. All data are represented as ± SEM. *, P<0.05; **, P<0.01; ***,
P<0.001. n.s., non-significant, n.d., not detected.
3.3.4 ex vivo cultured TG2-/- mice skin shows reduced
MMP-13 expression after UVB irradiation
Skin is relatively easy to organ culture than other kind of organs (129, 130).
When compared with cell-culture system, skin organ culture system shows 
characteristics of skin more clearly as the tissue architecture remains intact as 
well as cell-cell interactions are relatively undisturbed. Furthermore, it is also 
possible to minimize the infiltration of immune cells under inflammatory 
conditions such as UV irradiation, thereby helping to eliminate the effects of 
undesirable cell types. Therefore, it is a suitable method to explore various 
aspects of pathophysiology of skin biology.
Neonatal mouse skin was prepared and UV irradiated as described in Fig. 3-
5A. Mouse MMP-13 protein level was measured 24 h after UV irradiation by 
western blotting. UV-irradiated WT skins showed increased expression of 
MMP-13 about 5 times higher than non-irradiated WT skin (Fig. 3-5B). 
However, the skins obtained from TG2-/- mice failed to express MMP-13 
protein after UV irradiation (Fig. 3-5B). Although p-p65Ser536 expression was 
reduced after UVB irradiation, it may be attributed to our late time point
observation. In addition, the expression of IBan inhibitory protein of NF-
B, was not different between the TG2-/- and WT skin. In previous data, it was 
concluded that TG2 does not regulate expression of c-Jun (Fig. 3-4A and B). 
Similar with this data, we could not observe different expression of c-Jun nor 
of p38, the upstream regulator of c-Jun, between the WT and TG2-/- skin. These 
results reinforce our conclusion that TG2 does not regulate human MMP-1 and 
mouse MMP-13 expressions through AP-1 pathway.
Figure 3-5. Reduced MMP13 expression in TG2 -/- mice skin after UVB 
irradiation. (A) Schematic figure of neonate mouse skin organ culture and UV 
irradiation. (B) Western blot analysis of the skin lysate 24 h after UV irradiation. 
Actin was used as a loading control. MMP-13 protein level were quantified by 
ImageJ software (Right panel, n=4). Data are represented as mean± SEM. **,
P<0.01; ***, P<0.001.
3.4 DISCUSSION
Through the skin, organisms primarily interact with surrounding environments.
It is simultaneously exposed to UV radiation on regular bases, which leads to 
the development of photoaging and skin cancer through inflammation, DNA 
damage and immune suppression (67). In the previous study, we clarified that 
TG2, expressed in epidermal keratinocytes, mediates UV-induced acute skin
inflammation through regulation of expressions of inflammatory cytokines, 
such as IL-6, IL-8 and TNF-(103). Besides epidermis, dermis also abundantly 
expresses TG2. Dermis provides mechanical characteristics of skin and 
primarily consists of fibroblasts. However, the role of fibroblast TG2 has not 
been fully characterized yet. Herein, we showed that fibroblast TG2 is a critical 
regulator of UV-induced MMPs expressions. Moreover, our results prove that 
TG2 regulates MMPs expression through NF-|	 |P-1
pathway. Collectively, these results indicate that TG2 is an enzyme that 
participates in dermal remodeling following UV-irradiation.
In this study, TG2 regulates MMPs expressions at transcriptional level. The 
major transcription factors that regulate MMPs expressions are AP-1 and NF-
B (122, 123, 125). In this respect, it can be presumed that TG2 is a regulator 
of AP-1 or NF-B. AP-1 is a dimeric transcription factor composed of Jun (c-
Jun, JunD, JunB), Fos (c-Fos, FosB, Fra-1, Fra-2), and ATF (ATF-2, ATFa) 
families and is involved in cellular proliferation, transformation and death (121). 
Among the various combinations, heterodimer of c-Jun/c-Fos is common in the 
cells. There is some research about the role of TG2 in regulating AP-1 pathway. 
TG2 participates in A"-42-induced inflammatory activation in monocytes via 
AP-1 pathway (131) and induces JNK activation, one of upstream kinases of c-
Jun (132, 133). However, in this study, we observed that TG2 did not affect AP-
1 activity and c-Jun protein level at cellular and at tissue levels following UV 
irradiation. These data indicate that TG2 regulates c-Jun in cell type- and 
stimulation-specific manner. Instead, several lines of evidence indicate that 
TG2 positively regulates NF-B activity (74, 82, 103), however the exact 
regulatory mechanisms remain unidentified. Moreover, we observed that TG2 
regulates transcriptional activity of NF-B and affects phosphorylation status 
of p65 at Ser468 in the nucleus. It is suggested that phosphorylation of p65 at 
Ser468 negatively regulates NF-B activity (126, 127), as this phosphorylation 
site is associated with proteolytic degradation of p65 (128). Consistent with 
these studies, TG2 knock-down and inhibitor treatment induced degradation of 
p65 in the nucleus. This implies that TG2-mediated NF-B activation 
specifically modulates the target genes rather than the universal manner since 
p-p65Ser468 is known to be a marker of target gene specific degradation of p65 
(128). This is supported by the observation of collagen gene expression. 
Although, NF-B activation is known to inhibit collagen gene transcription
(134, 135), TG2 did not affect the expression of collagen in this study. The 
concept of target gene specific regulation of TG2-NF-B signaling could be 
demonstrated by comparing the status of p-p65Ser468 on MMP and collagen 
promoter through techniques such as chromatin immunoprecipitation (ChIP).
Although we observed TG2-mediated regulation of p-p65Ser468, its molecular
mechanism is still unclear. It is known that some kinases target this 
phosphorylation residue. GSK3"is responsible for basal phosphorylation (127),
TNF-or IL-1 stimulation induces IKK"-mediated phosphorylation (126) and 
IKK]is known to be responsible for phosphorylation of T cells (136). However, 
UV irradiation induces phosphorylation of GSK3"at Ser9 (137, 138) which 
inactivates its kinase activity. Furthermore, it is suggested that UV irradiation 
does not induce IKK"activation (139, 140), instead IKK"acts as an adaptor 
protein for IBdegradation in the nucleus of UV-irradiated cells (141). There 
is no evidence about UV irradiation regulates IKK]activity at the present time. 
These data suggest that these kinases are not responsible for the p-p65Ser468
following UV irradiation. Besides kinases, phosphatases also target this 
phosphorylation residue (126, 127). UV radiation has been reported to decrease 
phosphatase 1 (PP1) activity (142). Moreover, it has also been reported that 
TG2 regulates JNK phosphorylation through downregulation protein 
phosphatase 2A (PP2A) (132). In this regard, it will be worth investigating 
whether TG2 regulates phosphorylation of p65 through modulating 
phosphatase activity or not. 
In summary, we have shown that fibroblasts TG2 plays a critical role in 
regulating MMP-1, -3 and -13 expression under UV irradiation. UV-induced 
activation of TG2 promotes transcriptional activation of NF-B but not AP-1, 
which leads to increased production of MMPs. These findings indicate that TG2 
plays a pivotal role in MMPs-mediated skin remodeling induced by UV light 
and inhibition of fibroblast TG2 following UV irradiation will be a useful target 
for the prevention of photoaging caused by MMPs which is induced by chronic 
UV exposure.
General Discussion
The development and evaluation of anti-melanogenic agents has been actively 
studied for not only alleviate pigmentary disorders cosmetically and medically, 
but also for melanoma treatment in which melanogenesis level is one of crucial 
factors for chemo-/radio- therapy as well as survival period of patients (143, 
144). There are some strategies for anti-melanogenesis including tyrosinase 
inhibition, inhibition of melanosome transfer, acceleration of epidermal 
turnover and desquamation, and antioxidant application (145).
In chapter 1, a new anti-melanogenic mechanism of 4-n-butylresorcinol
which is used as an inhibitor of tyrosinase was elucidated. Although, there are 
several cellular and clinical studies clarified the efficacy of 4-n-butylresorcinol, 
all of these studies focused on only the inhibitory ability against tyrosinase. In 
this study, it was observed that 4-n-butylresorcinol inhibits tyrosinase more 
effectively in live cell condition than in cell lysate. It suggests that there is 
another regulatory mechanism of 4-n-butylresorcinol in addition to the 
tyrosinase inhibitor. Indeed, 4-n-butylresorcinol treated cells decreased the 




level. This means that 4-n-butylresorcinol regulates tyrosinase at 
posttranslational level. Tyrosinase is one of the representative proteins that
undergoes glycosylation in the ER and Golgi, which is critical for its proper 
folding and trafficking to the melanosomes (41). Aberrant glycosylation of 
tyrosinase induces ER retention of the protein that leads proteasomal 
degradation of the protein which is known as ER-associated degradation 
(ERAD) (25-27). Indeed, several agents are known to affect glycosylation of 
tyrosinase (27, 146, 147). However, we could not find any evidences for 
involvement of 4-n-butylresorcinol in this process. Instead, 4-n-butylresorcinol 
has been shown to accelerate the proteolytic degradation of tyrosinase through 
both of endosomal/lysosomal and proteasomal pathway, which is partially 
related to phosphorylation status of p38 MAPK. There are some possible 
hypotheses for explaining 4-n-butylresorcinol-mediated degradation of 
tyrosinase which is mentioned in the discussion section of Chapter 1, which 
should be tested.
Although, the degradative pathway of tyrosinase was focused in this study, 
it will be also worth investigating the antioxidant property of 4-n-
butylresorcinol. Oxidative condition is favored to melanogenesis as tyrosinase 
prefers superoxide anion radical (O2-) over O2 for its enzyme activity (148).
Furthermore, redox agents can affect melanogenesis by interacting with active 
site copper of tyrosinase (149). Resorcinol and its derivatives, especially, are 
known to have antioxidant properties (150-152). Moreover, it was observed that 
4-n-butylresorcinol actually acts as an antioxidant both in vitro and at the 
cellular level (unpublished data). These data indicate that 4-n-butylresorcinol 
can inhibit melanogenesis through multifunctional approaches.
Transglutaminase 2 mediates posttranslational modification of substrates 
proteins (52) and is activated by various factors including reactive oxygen 
species (ROS), UV, irradiation, hypoxia and etc. (153). 
In chapter 2 and 3, the role of TG2 in UV-irradiated epidermal keratinocytes 
and dermal fibroblasts was investigated. In these studies, it was discovered that 
TG2 has central roles for the UV irradiation-mediated production of 
inflammatory cytokines and MMPs in keratinocyte and fibroblasts, respectively. 
Even though, it was known that UV irradiation activates TG2, the exact 
molecular mechanisms were not clear. From these studies, it was clarified that 
UV activates TG2 via activating PLC-IP3-IP3R pathway, followed by the ER 
calcium release. Furthermore, it was revealed that activated TG2 enhances 
transcriptional activity of NF-
al player that mediates UV-
induced production of inflammatory cytokines and MMPs in keratinocytes and 
fibroblasts, respectively. Although, there are explanations for the molecular 
mechanisms of TG2-induced NF-|(74, 82), it is still controversial 
and more studies need to be done. In this study, it was observed that TG2 
regulates the phosphorylation status of p65. Inhibition or knockdown of TG2 
decreased phosphorylation of Ser536 which is related with transcriptional 
activity of p65 (101) in keratinocytes. Moreover, TG2 does not affect nuclear 
translocation of p65, but instead affects Ser468 phosphorylation followed by 
nuclear degradation of p65 in fibroblasts. This phosphorylation site is known 
as a residue for target gene specific degradation of p65 (128). That is, it seems 
that TG2 regulates NF-by regulating p65 stability in the nucleus 
rather than facilitating nuclear translocation of p65 following UV irradiation. 
However, it is uncertain how TG2 modulates phosphorylation status of p65 at 
the present stage. Phosphorylation of p65 is regulated by both of kinases and 
phosphatases. Although {@"(127) |}"(126) are responsible for the 
phosphorylation of p65 at Ser468, the possibility of TG2-mediated regulation 
of these kinases seems low
|	}|}	
|	"
(139, 140) |} |
 {@"  (137, 138). Instead, protein 
phosphatases mediated mechanism seems more plausible since TG2 
downregulates protein phosphatase 2A (PP2A) (132). Furthermore, it was 
suggested that UV irradiation inhibits phosphatase 1 (PP1) activity (142). The 
study about the relationship between TG2 and phosphatases might suggest a 
new insight for the molecular mechanism of TG2-mediated NF-|
Although, TG2 is an enzyme, the importance of enzyme activity of TG2 has 
been overlooked so far. UV irradiation to the cells induces generation of 
reactive oxygen species (ROS) (7) and ER calcium release into the cytoplasm 
(80) which are indispensable factors for TG2 activation. Chapter 2 and 3 discuss 
the importance of enzyme activity of TG2 in the production of inflammatory 
cytokines and MMPs following UV irradiation by using TG2 inhibitor, 
KCC009. Even though more studies need to be done to clarify the effector 
molecules of activated TG2 and their biological significance, these data indicate 
that enzyme activity of TG2 should be considered under conditions of stress
which can activate TG2.
It has been suggested that cytokines can regulate skin ECM remodeling via 
paracrine and autocrine fashions (154). Since keratinocyte-derived cytokines 
can penetrate into the basement membrane (155), fibroblasts can be influenced 
by these cytokines. In chapter 2, we reported that UV-induced activation of 
keratinocyte TG2 regulates inflammatory cytokines expressions such as IL-6, 
IL-8 and TNF- (103). TNF-	}	
-1 and MMP-3 expressions in 
various cell types (156-159) through NF-(160) and c-Jun (161) pathways.
In addition, IL-6 induces MMP-1 induction in fibroblasts (105, 162, 163).
Moreover, these cytokines induce infiltration of immune cells, such as 
neutrophils and macrophages. In particular, these immune cells are observed in 
the lesions of UV exposed skin (164, 165) and release MMPs to further degrade 
ECM at the irradiated sites (110, 164). TG2-/- mice showed reduced infiltration 
of immune cells into the UV-irradiated lesion, as discussed in chapter 2 (103).
From these data, a hypothetical model of TG2-mediated remodeling of dermal 
ECM can be suggested (Fig. 4-1). First, TG2 directly regulates MMP-1, -3 and 
-13 expression through NF--dependent pathway in UV-irradiated fibroblasts. 
Secondly, TG2 of UV-irradiated keratinocytes mediates secretion of 
inflammatory cytokines such as IL-6 and TNF-(103). These cytokines might 
reach to the dermal fibroblasts and induce MMPs expressions via paracrine 
manner. Finally, keratinocyte-derived cytokines induce infiltration of immune 
cells. These immune cells release various matrix-degrading enzymes like 
MMPs. All of these situations will contribute to the pathological alterations of 
UV-damaged skin, such as inflammation, photoaging and photocarcinogenesis.
In conclusion, molecular mechanisms of skin cells, such as melanocyte, 
keratinocyte and fibroblast, were investigated after UV irradiation in this study. 
Research and understanding the influence of UV at molecular level are 
important for human health since we have ‘functionally naked’ skin. Through 
this study, we will be able to broaden our understanding of skin responses after 
exposure to UV light at the molecular level and establish new strategies to 
control the harmful effects of UV light.
Figure 4-1. Hypothetical model of TG2-mediated dermal ECM remodeling.
In fibroblasts, UV-induced TG2 activation positively regulates NF-
followed by induction of its target genes including MMP-1, -3 and -13, directly 
(green arrow). Meanwhile, UV-irradiated keratinocytes release inflammatory 
cytokines in TG2-dependent fashion. These cytokines reach dermal fibroblasts 
and facilitate expression of MMP genes, indirectly (blue arrows). Finally, 
cytokines promote infiltration of immune cells to the UV-irradiated lesion. 
These immune cells release ECM degrading enzymes such as MMPs (orange 
arrows).
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